JPH0592995A - 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2 - Google Patents

125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2

Info

Publication number
JPH0592995A
JPH0592995A JP3013849A JP1384991A JPH0592995A JP H0592995 A JPH0592995 A JP H0592995A JP 3013849 A JP3013849 A JP 3013849A JP 1384991 A JP1384991 A JP 1384991A JP H0592995 A JPH0592995 A JP H0592995A
Authority
JP
Japan
Prior art keywords
added
group
reduced pressure
under reduced
boc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3013849A
Other languages
Japanese (ja)
Inventor
Ko Morita
香 森田
Shigeo Kuzuki
茂夫 葛木
Toshiharu Noda
俊治 野田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP3013849A priority Critical patent/JPH0592995A/en
Publication of JPH0592995A publication Critical patent/JPH0592995A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PURPOSE:To obtain the subject radioactive labeled substance composed of a new human parathyroid hormone derivative and useful for the parathyroid function assay, etc., by labeling tyrosine residue at a specific position of a peptide having a specific amino acid sequence with plural 125I atoms. CONSTITUTION:A protected peptide is synthesized by converting the carboxyl group of a C-terminal tyrosine group to amide group and successively condensing amino acids according to the amino acid sequence of the peptide by liquid-phase synthesis after protecting the alpha-amino group and side-chain functional group. The protected peptide is treated with anhydrous hydrogen fluoride, etc. to eliminate the protecting groups and purified by gel-filtration, ion-exchange column chromatography and highperformance liquid chromatography to obtain the human parathyroid hormone (h-PTH) expressed by formula. The objective radioactive substance containing the peptide of formula wheremn the 34th Tyr is labeled with one or two 125I atoms is produced by incorporating and reacting the h-PTH with a phosphate buffer solution containing 125-Nal and chloramine T.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規なヒト副甲状腺ホ
ルモン(h−PTH)誘導体に関する。さらに詳しく
は、本発明は、副甲状腺機能検査のための標識化合物と
して有用な〔Nle8 ,Nle18,Tyr34〕−h−P
TH(1−34)NH2 、即ち式 H−配列番号:1−NH2 〔I〕 (式中、SerはL−セリン、ValはL−バリン、G
luはL−グルタミン酸、IleはL−イソロイシン、
GlnはL−グルタミン、LeuはL−ロイシン、NI
eはL−ノルロイシン、HisはL−ヒスチジン、As
nはL−アスパラギン、Glyはグリシン、LysはL
−リジン、ArgはL−アルギニン、TrpはL−トリ
プトフアン、AspはL−アスパラギン酸、TyrはL
−チロシンを示す〕で表されるペプチドの34番目のT
yrが1〜2個の125 Iで標識された放射活性体(以
下、単に125 I標識放射活性体と称することがある)で
ある。
TECHNICAL FIELD The present invention relates to a novel human parathyroid hormone (h-PTH) derivative. More specifically, the present invention is useful as a labeled compound for testing parathyroid function [Nle 8 , Nle 18 , Tyr 34 ] -hP.
TH (1-34) NH 2 , that is, the formula H-SEQ ID NO: 1-NH 2 [I] (wherein Ser is L-serine, Val is L-valine, G
lu is L-glutamic acid, Ile is L-isoleucine,
Gln is L-glutamine, Leu is L-leucine, NI
e is L-norleucine, His is L-histidine, As
n is L-asparagine, Gly is glycine, Lys is L
-Lysine, Arg is L-arginine, Trp is L-tryptophan, Asp is L-aspartic acid, Tyr is L
-Indicating tyrosine], the 34th T of the peptide represented by
It is a radioactive substance labeled with 125 I having 1-2 yrs (hereinafter, may be simply referred to as 125 I-labeled radioactive substance).

【0002】[0002]

【従来の技術】h−PTHは84個のアミノ酸よりなる
ペプチドホルモンで、その生物学的活性はアミノ酸順位
1−34のN末端フラグメント、即ちh−PTH(1−
34)に有ると報告されている〔Proc.Nat.A
cad.Sci.U.S.A.,68,63〜67)
(1971)〕。しかしながら、h−PTHはL−メチ
オニン(Met)が存在するため不安定であり、125
で標識するとホルモン活性が失われる〔Recent
Prog.Hormone Res.,18,269〜
295(1962)〕。
2. Description of the Prior Art h-PTH is a peptide hormone consisting of 84 amino acids and its biological activity is h-PTH (1-
34) [Proc. Nat. A
cad. Sci. U. S. A. , 68 , 63-67)
(1971)]. However, h-PTH is unstable due to the presence of L-methionine (Met), and 125 I
When labeled with, the hormone activity is lost [Recent
Prog. Hornone Res. , 18 , 269 ~
295 (1962)].

【0003】[0003]

【発明が解決しようとする課題】従来のh−PTHの定
量法では、h−PTH活性を有する部分のみを定量する
ために、h−PTH(1−34)を抗原とした特異抗体
が調製されるようになった。しかしながら、h−PTH
(1−34)は、L−メチオニン(Met)が存在する
ため不安定であり、125 Iで標識化する際、8位および
18位に存在するMetが酸化されてホルモン活性が失
活するという欠点があった。
In the conventional method for quantifying h-PTH, a specific antibody using h-PTH (1-34) as an antigen was prepared in order to quantify only a portion having h-PTH activity. It became so. However, h-PTH
(1-34) is unstable due to the presence of L-methionine (Met), and when labeled with 125 I, Met at the 8th and 18th positions is oxidized and hormone activity is inactivated. There was a flaw.

【0004】そこで、PTH活性を有し、PTHの抗体
に対して免疫活性を有するのみならず、125 Iで標識化
してもホルモン活性が安定であり、且つ安定な放射活性
を有するh−PTH誘導体として、8位および18位の
MetをL−ノルロイシンに換え、34位のL−フエニ
ルアラニンをL−チロシンに換えた〔Nle8 ,Nle
18,Tyr34〕−h−PTH(1−34)が見出された
〔特開昭55−113753号〕。
Therefore, an h-PTH derivative having a PTH activity and an immunological activity against an antibody of PTH, and having a stable hormone activity even when labeled with 125 I and having a stable radioactivity. As a result, Met at the 8th and 18th positions was changed to L-norleucine, and L-phenylalanine at the 34th position was changed to L-tyrosine [Nle 8 , Nle.
18 , Tyr 34 ] -h-PTH (1-34) was found [JP-A-55-113753].

【0005】しかしながら、この〔N1e8 ,Nl
18,Tyr34〕−h−PTH(1−34)は、その分
子内にMetが存在しないため、125 Iで標識しても失
活しないが、そのホルモン活性は高々天然型h−PTH
(1−34)と同程度の活性を有するに過ぎなかった。
However, this [N1e 8 , Nl
e 18 , Tyr 34 ] -h-PTH (1-34) does not inactivate even when labeled with 125 I because Met does not exist in the molecule, but its hormone activity is at most natural h-PTH.
It was only as active as (1-34).

【0006】[0006]

【課題を解決するための手段】本目的化合物〔I〕はP
THのレセプターに対し公知のh−PTH(1−34)
および〔Nle8 ,Nle18,Tyr34〕−h−PTH
(1−34)よりも強い親和力を有し、約1.5〜2倍
のh−PTH活性を有するのみならず、PTHの抗体に
対しても免疫活性を有し、125 Iで標識してもホルモン
活性は低下せず、〔Nle8 ,Nle18,Tyr34〕−
h−PTH(1−34)より約2倍の放射活性を有して
おり、長期の保存においても生物活性が低下しないた
め、公知のh−PTH(1−34)、〔Nle8 ,Nl
18,Tyr34〕−h−PTH(1−34)より極めて
優れた効果を発揮する。このため、本目的化合物〔I〕
は副甲状腺機能検査のための標識化合物として極めて有
用なペプチドである。
The object compound [I] is P
Known h-PTH (1-34) for TH receptor
And [Nle 8 , Nle 18 , Tyr 34 ] -h-PTH
It has a stronger affinity than (1-34), has not only about 1.5 to 2 times the activity of h-PTH, but also has an immunological activity against the antibody of PTH and is labeled with 125 I. However, the hormonal activity did not decrease, and [Nle 8 , Nle 18 , Tyr 34 ]-
It has about twice as much radioactivity as h-PTH (1-34), and its biological activity does not decrease even after long-term storage. Therefore, known h-PTH (1-34), [Nle 8 , Nl
e 18 , Tyr 34 ] -h-PTH (1-34) exhibits a significantly superior effect. Therefore, the target compound [I]
Is a peptide that is extremely useful as a labeling compound for parathyroid function tests.

【0007】本発明のペプチド〔I〕は、C末端チロシ
ル基のカルボキシル基をアミド基に転化し、式〔I〕で
示されるアミノ酸順序に個々の保護されたアミノ酸およ
び(または)保護された低級ペプチドを液相合成法によ
り縮合し、縮合反応の最終段階でN末端のアミノ基の保
護基および側鎖の官能基の保護基を酸分解により脱離す
ることにより得られる。縮合反応自体はペプチド合成の
ための常法手段に従って、保護基の着脱、縮合反応を繰
り返すことにより行われる。即ち、本ペプチド〔I〕の
原料ならびにすべての中間体の製造において使用される
各種保護基はペプチド合成で既知なもの、従って加水分
解、酸水解、還元、アミノリシスまたはヒドラジノリシ
スの既知手段によって容易に脱離することのできる保護
基が用いられる。このような保護基はペプチド合成化学
の分野の文献ならびに参考書に記載されている。
The peptide [I] of the present invention converts the carboxyl group of the C-terminal tyrosyl group into an amide group to give individual protected amino acids and / or protected lower amino acids in the amino acid sequence represented by the formula [I]. It can be obtained by condensing a peptide by a liquid phase synthesis method and removing the protecting group of the amino group at the N-terminal and the protecting group of the functional group of the side chain by acidolysis at the final stage of the condensation reaction. The condensation reaction itself is carried out by repeating the attachment / detachment of a protecting group and the condensation reaction according to a conventional method for peptide synthesis. That is, the various protective groups used in the production of the starting material of the peptide [I] and all the intermediates are known in peptide synthesis, and therefore can be easily prepared by known means such as hydrolysis, acid hydrolysis, reduction, aminolysis or hydrazinolysis. A protecting group that can be eliminated is used. Such protecting groups are described in literatures and reference books in the field of synthetic peptide chemistry.

【0008】例えば、アミノ基に使用する保護基として
は、ホルミル基、トリフルオロアセチル基、フタロイル
基、p−トルエンスルホニル基、o−ニトロフエニルス
ルフェニル基などのアシル基、ベンジルオキシカルボニ
ル基、o(またはp)−ブロモベンジルオキシカルボニ
ル基、o(またはp)−クロロベンジルオキシカルボニ
ル基、p−ニトロベンジルオキシカルボニル基、p−メ
トキシベンジルオキシカルボニル基などのベンジルオキ
シカルボニル基、トリクロロエチルオキシカルボニル
基、t−ブチルオキシカルボニル基、t−アミルオキシ
カルボニル基、ジイソプロピルメチルオキシカルボニル
基などの脂肪族オキシカルボニル基、2−フエニル−イ
ソプロポキシカルボニル基、2−トリル−イソプロポキ
シカルボニル基、2−p−ジフエニル−イソプロポキシ
カルボニル基などのアラルキルオキシカルボニル基など
がある。また、これらアミノ基をベンゾイルアセトン、
アセチルアセトンなどの1,3−ジケトンと反応させる
ことによって得られるエナミンの形成により保護するこ
とができる。
For example, as a protecting group used for an amino group, an acyl group such as a formyl group, a trifluoroacetyl group, a phthaloyl group, a p-toluenesulfonyl group, an o-nitrophenylsulfenyl group, a benzyloxycarbonyl group, benzyloxycarbonyl group such as o (or p) -bromobenzyloxycarbonyl group, o (or p) -chlorobenzyloxycarbonyl group, p-nitrobenzyloxycarbonyl group, p-methoxybenzyloxycarbonyl group, trichloroethyloxycarbonyl group Group, t-butyloxycarbonyl group, t-amyloxycarbonyl group, aliphatic oxycarbonyl group such as diisopropylmethyloxycarbonyl group, 2-phenyl-isopropoxycarbonyl group, 2-tolyl-isopropoxycarbonyl group, 2 p- diphenyl - and the like aralkyloxycarbonyl groups such as isopropoxycarbonyl group. In addition, these amino groups are benzoylacetone,
It can be protected by the formation of the enamine obtained by reacting with a 1,3-diketone such as acetylacetone.

【0009】カルボキシル基は、アミド形成、ヒドラチ
ド形成またはエステル化によって保護される。即ちアミ
ド基は、3,4−ジメトキシベンジル基、ビス−(p−
メトキシフエニル)メチル基などによって置換される。
ヒドラチド基はベンジルオキシカルボニル基、トリクロ
ロエチルオキシカルボニル基、トリフルオロアセチル
基、t−ブチルオキシカルボニル基、トリチル基、2−
p−ジフエニル−イソプロポキシカルボニル基などによ
って置換される。エステル基はメタノール、エタノー
ル、t−ブタノール、シアノメチルアルコールなどのア
ルカノール、ベンジルアルコール、p−ブロモベンジル
アルコール、p−クロロベンジルアルコール、2,6−
ジクロロベンジルアルコール、p−メトキシベンジルア
ルコール、p−ニトロベンジルアルコール、ベンズヒド
リルアルコール、ベンゾイルメチルアルコール、p−ブ
ロモベンゾイルメチルアルコール、p−クロロベンゾイ
ルメチルアルコールなどのアラルカノール、2,4,6
−トリクロロフエノール、2,4,5−トリクロロフエ
ノール、ペンタクロロフエノール、p−ニトロフエノー
ル、2,4−ジニトロフエノールなどのフエノール、チ
オフエノール、p−ニトロチオフエノールなどのチオフ
エノールなどによって置換される。
Carboxyl groups are protected by amide formation, hydratide formation or esterification. That is, the amide group is 3,4-dimethoxybenzyl group, bis- (p-
Methoxyphenyl) methyl group and the like.
The hydratide group is benzyloxycarbonyl group, trichloroethyloxycarbonyl group, trifluoroacetyl group, t-butyloxycarbonyl group, trityl group, 2-
It is substituted with a p-diphenyl-isopropoxycarbonyl group and the like. Ester groups include alkanols such as methanol, ethanol, t-butanol and cyanomethyl alcohol, benzyl alcohol, p-bromobenzyl alcohol, p-chlorobenzyl alcohol, 2,6-
Aralkanols such as dichlorobenzyl alcohol, p-methoxybenzyl alcohol, p-nitrobenzyl alcohol, benzhydryl alcohol, benzoylmethyl alcohol, p-bromobenzoylmethyl alcohol and p-chlorobenzoylmethyl alcohol, 2,4,6
-Substituted by trichlorophenol, 2,4,5-trichlorophenol, pentachlorophenol, p-nitrophenol, phenol such as 2,4-dinitrophenol, thiofenool, thiofenool such as p-nitrothiofenool, and the like.

【0010】前記セリンおよびチロシンの水酸基は、例
えばエステル化またはエーテル化によって保護すること
ができる。このエステル化に適する基としては、例えば
アセチル基、ベンゾイル基、ベンジルオキシカルボニル
基、エチルオキシカルボニル基などである。またエーテ
ル化に適する基としては、例えばベンジル基、2,6−
ジクロロベンジル基、テトラヒドロピラニル基、t−ブ
チル基である。これらの水酸基の保護には2,2,2−
トリフルオロ−1−t−ブチルオキシカルボニルアミノ
エチル基、2,2,2−トリフルオロ−1−ベンジルオ
キシカルボニルアミノ基も適する。しかしながら、これ
らの水酸基を必ずしも保護する必要はない。
The hydroxyl groups of serine and tyrosine can be protected by, for example, esterification or etherification. Suitable groups for this esterification include, for example, acetyl group, benzoyl group, benzyloxycarbonyl group, ethyloxycarbonyl group and the like. Examples of the group suitable for etherification include benzyl group and 2,6-
A dichlorobenzyl group, a tetrahydropyranyl group and a t-butyl group. To protect these hydroxyl groups 2,2,2-
A trifluoro-1-t-butyloxycarbonylaminoethyl group and a 2,2,2-trifluoro-1-benzyloxycarbonylamino group are also suitable. However, it is not always necessary to protect these hydroxyl groups.

【0011】前記アルギニンのグアニジン基中のアミノ
基を保護するのに使用する基としては、例えばニトロ
基、トシル基、ベンジルオキシカルボニル基、メシチレ
ン−2−スルホニル基などであるが、このグアニジノ基
を必ずしも保護する必要はない。前記ヒスチジンのイミ
ノ基を保護するのに使用する基としては、例えばベンジ
ル基、トリチル基、ベンジルオキシカルボニル基、トシ
ル基、2,2,2−トリフルオロ−1−t−ブチルオキ
シカルボニルアミノエチル基、2,2,2−トリフルオ
ロ−1−ベンジルオキシカルボニルアミノエチル基など
であるが、このイミノ基を必ずしも保護する必要はな
い。
Examples of the group used to protect the amino group in the guanidine group of arginine include a nitro group, a tosyl group, a benzyloxycarbonyl group and a mesitylene-2-sulfonyl group. It does not necessarily have to be protected. Examples of the group used for protecting the imino group of histidine include a benzyl group, a trityl group, a benzyloxycarbonyl group, a tosyl group, and a 2,2,2-trifluoro-1-t-butyloxycarbonylaminoethyl group. , 2,2,2-trifluoro-1-benzyloxycarbonylaminoethyl group and the like, but it is not always necessary to protect this imino group.

【0012】本発明においては、α−アミノ基の保護に
t−ブチルオキシカルボニル基、t−アミルオキシカル
ボニル基を用い、側鎖のアミノ基、即ちリジンのε−ア
ミノ基の保護にo−クロロベンジルオキシカルボニル基
を用い、α−カルボキシル基の保護にベンジルエステル
基、エチルエステル基、フエナシルエステル基を用い、
側鎖のカルボキシル基、即ちグルタミン酸、アスパラギ
ン酸の側鎖カルボキシシル基の保護にベンジルエステル
基を用い、セリンの水酸基の保護にベンジル基を用い、
チロシンの水酸基の保護に2,6−ジクロロベンジル基
を用い、アルギニンのグアニジン基中のアミノ基の保護
にトシル基またはメシチレン−2−スルホニル基を用い
るのが好ましい。
In the present invention, a t-butyloxycarbonyl group and a t-amyloxycarbonyl group are used to protect the α-amino group, and an o-chloro group is used to protect the side chain amino group, that is, the ε-amino group of lysine. A benzyloxycarbonyl group is used, a benzyl ester group, an ethyl ester group, and a phenacyl ester group are used to protect the α-carboxyl group.
Side chain carboxyl group, that is, glutamic acid, a benzyl ester group is used to protect the side chain carboxysyl group of aspartic acid, and a benzyl group is used to protect the hydroxyl group of serine.
It is preferable to use a 2,6-dichlorobenzyl group for protecting the hydroxyl group of tyrosine and a tosyl group or a mesitylene-2-sulfonyl group for protecting the amino group in the guanidine group of arginine.

【0013】本目的化合物〔I〕の合成においては、個
々のアミノ酸および(または)低級ペプチドの縮合は、
例えば保護されたα−アミノ基および活性化末端カルボ
キシル基をもつアミノ酸またはペプチドと遊離のα−ア
ミノ基および保護された末端カルボキシル基をもつアミ
ノ酸またはペプチドとを反応させるか、あるいは活性化
α−アミノ基および保護された末端カルボキシル基をも
つアミノ酸またはペプチドと遊離の末端カルボキシル基
および保護されたα−アミノ基をもつアミノ酸またはペ
プチドを反応させることにより、実施することができ
る。
In the synthesis of the object compound [I], the condensation of individual amino acids and / or lower peptides is
For example, reacting an amino acid or peptide having a protected α-amino group and an activated terminal carboxyl group with an amino acid or peptide having a free α-amino group and a protected terminal carboxyl group, or activating an activated α-amino group. It can be carried out by reacting an amino acid or peptide having a group and a protected terminal carboxyl group with an amino acid or peptide having a free terminal carboxyl group and a protected α-amino group.

【0014】この場合、カルボキシル基は、例えば酸ア
ジド、酸無水物、酸イミダゾリドまたは活性エステル、
例えばシアノメチルエステル、チオフエニルエステル、
p−ニトロチオフエニルエステル、p−ニトロフエニル
エステル、2,4−ジニトロフエニルエステル、2,
4,5−トリクロロフエニルエステル、2,4,6−ト
リクロロフエニルエステル、ペンタクロロフエニルエス
テル、N−ヒドロキシコハク酸イミドエステル、N−ヒ
ドロキシフタル酸イミドエステルなどに変換することに
よって活性化することができる。またカルボジイミド、
例えばN,N’−ジシクロヘキシル−カルボジイミド、
N−エチル−N’−3−ジメチルアミノプロピル−カル
ボジイミド、N,N’−カルボニル−ジイミダゾールま
たはイソオキゾリウム塩、例えばウッドワード反応剤な
どの縮合剤を使用して反応させることによって活性化す
ることができる。
In this case, the carboxyl group is, for example, an acid azide, an acid anhydride, an acid imidazolide or an active ester,
For example, cyanomethyl ester, thiophenyl ester,
p-nitrothiophenyl ester, p-nitrophenyl ester, 2,4-dinitrophenyl ester, 2,
Activation by converting into 4,5-trichlorophenyl ester, 2,4,6-trichlorophenyl ester, pentachlorophenyl ester, N-hydroxysuccinimide ester, N-hydroxyphthalic acid imide ester, etc. You can Also carbodiimide,
For example, N, N'-dicyclohexyl-carbodiimide,
N-Ethyl-N'-3-dimethylaminopropyl-carbodiimide, N, N'-carbonyl-diimidazole or isooxolium salts, eg activated by reacting with a condensing agent such as Woodward Reactant. it can.

【0015】本発明において好ましい縮合方法は、アジ
ド法、活性エステル法およびカルボジイミド法である。
縮合の各段階ではラセミ化が起こらない方法またはラセ
ミ化が最少になる方法を用いるのが望ましく、好ましく
はアジド法、活性エステル法、ビュンシュ法〔Z.Na
turforsch.,21b,426(1966)〕
またはガイガー法〔Chem Ber.,103,78
8(1970)〕とりわけ縮合剤としてN−エチル−
N’−3−ジメチルアミノプロピル−カルボジイミド
(WSC)を用いる変法などを用いるのが適する。
Preferred condensation methods in the present invention are azide method, active ester method and carbodiimide method.
At each stage of the condensation, it is desirable to use a method in which racemization does not occur or a method in which racemization is minimized, and the azide method, active ester method, Bünsch method [Z. Na
Tursch. , 21b, 426 (1966)].
Alternatively, the Geiger method [Chem Ber. , 103, 78
8 (1970)] Especially as a condensing agent, N-ethyl-
It is suitable to use a modified method or the like using N′-3-dimethylaminopropyl-carbodiimide (WSC).

【0016】縮合順序は式〔I〕で示されるアミノ酸順
序であれば、如何なる順序からも合成し得るが、C−末
端側から順次アミノ酸および(または)ペプチドを連結
せるのが好ましい。
The condensation sequence may be any sequence as long as it is the amino acid sequence represented by the formula [I], but it is preferable to connect amino acids and / or peptides sequentially from the C-terminal side.

【0017】例えば、29〜34番目のアミノ酸順序か
らなるC末端フラグメントと23〜28番目のアミノ酸
からなるペプチドフラグメントを縮合させるのがよい。
このC−末端フラグメントとヘキサペプチド23−28
を縮合させるにはWSCを用いるガイガー変法によって
行うのが適する。得られたC−末端フラグメント23−
34の前に18〜22番のアミノ酸順序からならなるペ
プチドフラグメントを連結させるのであるが、WSCを
用いるガイガー変法により行うのが適する。得られたC
−末端フラグメント18−34の前に順次13〜17番
のアミノ酸順序からならなるペプチドフラグメント、8
〜12番のアミノ酸順序からならなるペプチドフラグメ
ント、1〜7番のアミノ酸順序からならなるペプチドフ
ラグメントを連結させるのが好ましい。
For example, a C-terminal fragment consisting of the 29th to 34th amino acid sequence and a peptide fragment consisting of the 23rd to 28th amino acid may be condensed.
This C-terminal fragment and hexapeptide 23-28
In order to condense, it is suitable to carry out by the Geiger modified method using WSC. The resulting C-terminal fragment 23-
A peptide fragment consisting of the amino acid sequence of the 18th to 22nd amino acids is ligated before 34, and it is suitable to use the Geiger modified method using WSC. The obtained C
A peptide fragment consisting of the sequence of amino acids 13 to 17 before the terminal fragment 18-34, 8
It is preferable to connect a peptide fragment consisting of the amino acid sequence of -12th and a peptide fragment consisting of the amino acid sequence of 1-7.

【0018】上記の縮合反応におけるα−アミノ基の保
護基、例えばt−ブチルオキシカルボニル基、t−アミ
ルオキシカルボニル基はトリフルオロ酢酸で脱離され
る。α−カルボキシル基の保護基、例えばエチルエスエ
ルはこれを希薄な水酸化ナトリウム溶液で分解し、また
はヒドラチドあるいはトリクロロエトキシカルボニルヒ
ドラチドのような保護ヒドラチドに変え、フエナシルエ
ステル基は酢酸中Zn粉末で分解し、またベンジルエス
テル基は無水弗化水素分解、水素添加分解によって分解
し、またはヒドラチドに変えることができる。
The protecting group for the α-amino group in the above condensation reaction, such as t-butyloxycarbonyl group and t-amyloxycarbonyl group, is eliminated with trifluoroacetic acid. The protecting group for the α-carboxyl group, such as ethyl ester, is decomposed with dilute sodium hydroxide solution or converted into a protective hydratide such as hydratide or trichloroethoxycarbonylhydratide, and the phenacyl ester group is Zn powder in acetic acid. When decomposed, the benzyl ester group can be decomposed by anhydrous hydrogen fluoride decomposition, hydrogenolysis, or converted to hydratide.

【0019】こうして保護されたN末端α−アミノ基、
ε−アミノ基、側鎖カルボキシル基、グアニジノ基およ
び(または)水酸基を有するテトラトリアコンタペプチ
ドが得られる。これらの保護基は、好ましくは酸分解、
例えば無水弗化水素またはトリフルオロメタンスルホン
酸による方法によって一段階で脱離され、式〔I〕の目
的化合物が得られる。
The N-terminal α-amino group thus protected,
A tetratriacontapeptide having an ε-amino group, a side chain carboxyl group, a guanidino group and / or a hydroxyl group can be obtained. These protecting groups are preferably acid-decomposed,
The target compound of the formula [I] is obtained by elimination in one step by a method using anhydrous hydrogen fluoride or trifluoromethanesulfonic acid.

【0020】このようにして得られたペプチド〔I〕
は、ペプチドまたは蛋白質を精製する公知の手段によっ
て分離精製することできる。例えば、セファデックスG
−25、セファデックスG−50、セファデックスLH
−20などのゲル濾過剤を用いるゲル濾過、カルボキシ
メチルセルロース、イオン交換樹脂などを用いるカラム
クロマトグラフイー、高速液体クロマトグラフイー等に
より行うことができる。
The peptide [I] thus obtained
Can be separated and purified by known means for purifying peptides or proteins. For example, Sephadex G
-25, Sephadex G-50, Sephadex LH
It can be carried out by gel filtration using a gel filtration agent such as -20, column chromatography using carboxymethyl cellulose, ion exchange resin or the like, high performance liquid chromatography and the like.

【0021】本発明のペプチド〔I〕は、その方法の条
件により塩基またはその塩の形で得られる。塩として
は、無機酸塩、ギ酸、酢酸、プロピオン酸、グリコール
酸、コハク酸、リンゴ酸、酒石酸、クエン酸などの有機
酸との塩である。
The peptide [I] of the present invention can be obtained in the form of a base or a salt thereof depending on the conditions of the method. The salt is an inorganic acid salt, a salt with an organic acid such as formic acid, acetic acid, propionic acid, glycolic acid, succinic acid, malic acid, tartaric acid, and citric acid.

【0022】さらに本発明のペプチド〔I〕の125 I標
識放射活性体は、例えば、一定量の放射活性を有する
125 I含有リン酸緩衝液(pH7.1)に前記ペプチド
〔I〕およびクロラミンTを加えて攪拌し、次いで重亜
硫酸ナトリウムを加え、さらに少量のヨウ化カリウムお
よび血清アルブミンを加えてクロマトグラフイーを行
い、125 Iで標識された分画を集めることにより、125
Iで標識された放射活性体が得られる。
Further, the 125 I-labeled radioactive substance of the peptide [I] of the present invention has, for example, a certain amount of radioactivity.
The above peptide [I] and chloramine T were added to 125 I-containing phosphate buffer (pH 7.1) and stirred, and then sodium bisulfite was added, and then a small amount of potassium iodide and serum albumin were added to perform chromatography. performed by collecting fractions labeled with 125 I, 125
A radioactive substance labeled with I is obtained.

【0023】上記125 I標識放射活性体は、高速液体ク
ロマトグラフイー(HPLC)などの精製手段により精
製できる。得られた精製体は、34番目のTyrの側鎖
のベンゼン環の水素が125 Iでモノまたはジ置換された
標識放射活性体である。本発明の125 標識放射活性体を
副甲状腺機能検査のための標識化合物として使用する場
合には、上記の125 Iモノ置換体およびジ置換体は個々
に分離して使用してもよく、また分離せずに使用しても
よい。
The 125 I-labeled radioactive substance can be purified by a purification means such as high performance liquid chromatography (HPLC). The obtained purified product is a labeled radioactive product in which hydrogen in the benzene ring of the side chain of the 34th Tyr is mono- or di-substituted with 125 I. When the 125- labeled radioactive substance of the present invention is used as a labeled compound for a parathyroid function test, the 125 I mono-substituted product and the di-substituted product described above may be used separately. You may use it without separating.

【0024】次に、本発明のペプチド〔I〕の125 I標
識放射活性体の副甲状腺ホルモン(PTH)活性につい
て述べる。 <125 I標識体の調製>2mCiの放射活性を有する
125 I−NaIを含有する0.5Mリン酸緩衝液(pH
7.1)50μlに各々h−PTH(1−34)、h−
PTH(1−34)NH2 、〔Nle8 ,Nle18,T
yr34〕−h−PTH(1−34)および〔Nle8
Nle18,Tyr34〕−h−PTH(1−34)NH2
の2μg含有液10μlおよびクロラミンT(3.5mg
/ml)含有液20μlを加えて30秒間攪拌した後、こ
れに重亜硫酸ナトリウム(4.5mg/ml)含有液50μ
lを加えて反応を停止した。これに5%ヒト血清アルブ
ミン含有0.1N酢酸溶液0.5mlを加えた後、セファ
デックスG−10のカラム(1×50cm)にチャージ
し、上記酢酸溶液で溶出して125 Iで標識した各被検品
の含有分画を得た。
Next, the parathyroid hormone (PTH) activity of the 125 I-labeled radioactive substance of the peptide [I] of the present invention will be described. <Preparation of 125 I-labeled product> Radioactivity of 2 mCi
0.5 M phosphate buffer containing 125 I-NaI (pH
7.1) 50 μl of h-PTH (1-34), h-
PTH (1-34) NH 2 , [Nle 8 , Nle 18 , T
yr 34] -h-PTH (1-34) and [Nle 8,
Nle 18 , Tyr 34 ] -h-PTH (1-34) NH 2
10 μl of a solution containing 2 μg of chloramine T and chloramine T (3.5 mg
/ Ml) containing solution (20 μl) and stirring for 30 seconds, and then adding sodium bisulfite (4.5 mg / ml) containing solution (50 μl)
The reaction was stopped by adding l. After adding 0.5 ml of a 0.1 N acetic acid solution containing 5% human serum albumin to this, the column was charged on a Sephadex G-10 column (1 x 50 cm), eluted with the acetic acid solution and labeled with 125 I. The contained fraction of the test product was obtained.

【0025】<PTH活性測定法> PTHレセプターの調製 SD系雄ラット(体重200〜250g)を断頭、放血
し、開腹の後、腎を摘出し、その表面皮膜を取り除き、
腎皮質部分を切り取り、氷冷する。以下の操作はできる
だけ低温(0〜4℃)下で行う。上記の腎皮質部分を
0.25Mシュクロースおよび1mMEDTA含有10
mMトリス塩酸塩緩衝液(pH7.5)(以下A液と称
す)中に浸し、テフロンペツスルを用いたガラス外套管
で腎皮質をその湿重量(g)の3倍容量(ml)のA液を
加えてホモゲナイズする。このホモジネートを150X
g、10分間遠心分離し、その上清をさらに2200X
g、15分間遠心分離する。上清を捨て、沈澱物の上層
の浮濁色の部分をA液に懸濁し、この懸濁液を2200
Xg、15分間遠心分離により洗浄し、再び懸濁して容
器に分注し、−70℃で凍結して−20℃で保存する。
<Method for measuring PTH activity> Preparation of PTH receptor Male SD rats (body weight: 200 to 250 g) were decapitated and exsanguinated, and after laparotomy, the kidney was removed and the surface film was removed.
Cut off the renal cortex and cool with ice. The following operations are performed at the lowest temperature (0 to 4 ° C). The above renal cortex part was added with 0.25 M sucrose and 1 mM EDTA.
The kidney cortex was dipped in mM Tris-hydrochloride buffer (pH 7.5) (hereinafter referred to as "A solution") with a glass mantle tube using Teflon pestle, and the amount of A was 3 times its wet weight (g) (ml). Add liquid and homogenize. 150X this homogenate
g, centrifuge for 10 minutes, and then add the supernatant to 2200X
g, centrifuge for 15 minutes. The supernatant is discarded, and the turbid color portion of the upper layer of the precipitate is suspended in solution A.
It is washed by centrifugation at Xg for 15 minutes, suspended again, dispensed in a container, frozen at -70 ° C and stored at -20 ° C.

【0026】PTHとPTHレセプターの反応 被検品を2μg/mlと10μg/mlの濃度になるように
ATPMg2mM、MgCl2 10mM、KCl60m
M、GTP20μM、イソブチルメチルキサンチン1m
M、クレアチンホスフエート8mMおよび牛血清アルブ
ミン(BSA)0.2%含有100mMトリス塩酸塩緩
衝液(pH7.5)(以下B液と称す)に溶かし、これ
を標準品牛PTH(1−84)について行う。
Reaction of PTH and PTH receptor ATPMg 2mM, MgCl 2 10mM, KCl 60m was added to the test sample so that the concentrations were 2 μg / ml and 10 μg / ml.
M, GTP 20 μM, isobutylmethylxanthine 1 m
M, creatine phosphate 8 mM and bovine serum albumin (BSA) 0.2% in 100 mM Tris-hydrochloride buffer (pH 7.5) (hereinafter referred to as solution B), which was dissolved in standard bovine PTH (1-84) Do about.

【0027】これら4つの溶液を50μlづつガラス試
験管に分注し、各々8本づつ用意する。試料は氷水中に
保ち、ATPなど他の物質の分解を抑える。−20℃に
保存したPTHレセプター調製品を室温で解凍し、A液
に予め溶かしておいたクレアチンキナーゼを加え、さら
にA液でクレアチンキナーゼ0.1mg/ml、PTHレセ
プター調製品蛋白量1.4mg/mlになるように調製し、
氷冷中で保つ。上記の分注された試料溶液を37℃の恒
温槽に数分間つけた後に、上記のPTHレセプター−ク
レアチンキナーゼ液を50μlづつ加え、37℃で10
分間インキュベートする。次いで、0.1M酢酸緩衝液
(pH4.0)100μlを加え、直ちに氷水中につけ
た後、速やかに試験管を沸騰水で1分間熱し、反応を停
止する。
50 μl of each of these 4 solutions is dispensed into a glass test tube, and 8 tubes each are prepared. Keep the sample in ice water to prevent decomposition of other substances such as ATP. Thaw the PTH receptor preparation stored at -20 ° C at room temperature, add creatine kinase previously dissolved in solution A, and further add creatine kinase 0.1 mg / ml in solution A and PTH receptor preparation protein amount 1.4 mg. / Ml, so that
Keep on ice. After the dispensed sample solution was placed in a constant temperature bath at 37 ° C. for several minutes, 50 μl of the PTH receptor-creatine kinase solution was added at 10 ° C. to 10 ° C.
Incubate for minutes. Then, 100 μl of 0.1 M acetate buffer (pH 4.0) is added and immediately put into ice water, and then the test tube is immediately heated with boiling water for 1 minute to stop the reaction.

【0028】生成C−AMPの測定 上記の反応停止試料を蒸留水で10〜30倍に希釈し、
2000XG、15分間の遠心分離により除蛋白を行
う。その上清のc−AMP量をRIAキット(ヤマサ醤
油社製)で測定する。
Measurement of C-AMP Produced The above reaction-stopped sample was diluted 10 to 30 times with distilled water,
Deproteinization is performed by centrifugation at 2000XG for 15 minutes. The amount of c-AMP in the supernatant is measured with a RIA kit (manufactured by Yamasa Shoyu Co., Ltd.).

【0029】PTH力価の測定 C−AMPの測定値をPM/mgPTHレセプター蛋白/
分の単位に換算し、これを反応の値とし、標準品によっ
て得られた値に対して被検品を平行線検定2×2点法を
用いて検定する。
Measurement of PTH titer The measured value of C-AMP is PM / mg PTH receptor protein /
It is converted into the unit of minutes, and this is used as the value of the reaction, and the value obtained by the standard product is tested by the parallel line test 2 × 2 point method.

【0030】PTH活性結果(U/mg)は表1の通り
である。
The results of PTH activity (U / mg) are shown in Table 1.

【表1】 [Table 1]

【0031】本明細書中に記載の略記号は次の意味を有
する。 Ser;L−セリン Val;L−バリン Glu;L−グルタミン酸 Ile;L−イソロイシン Gln;L−グルタミン Leu;L−ロイシン Nle;L−ノルロイシン His;L−ヒスチジン Asn;L−アスパラギン Gly;グリシン Lys;L−リジン Arg;L−アルギニン Trp;L−トリプトフアン Asp;L−アスパラギン酸 Tyr;L−チロシン Boc;t−ブチルオキシカルボニル Aoc;t−アミルオキシカルボニル Z−Cl;o−クロロベンジルオキシカルボニル Bzl;ベンジル Bzl−Cl2 ;2,6−ジクロロベンジル Tos;トシル OEt;エチルエステル OBzl;ベンジルエステル ONP;p−ニトロフエニルエステル OPAC;フエナシルエステル TFA;トリフルオロ酢酸 TosOH;p−トルエンスルホン酸 Et3 N;トリエチルアミン NMM;N−メチルモルホリン TBA;t−ブチルアミン DCHA;ジシクロヘキシルアミン NaOH;水酸化ナトリウム THF;テトラヒドロフラン DMF;ジメチルホルムアミド DMSO;ジメチルスルホキシド エーテル;ジエチルエーテル DCC;N,N’−ジシクロヘキシルカルボジイミド WSC;N−エチル,N’−3−ジメチルアミノプロピ
ル−カルボジイミド HOBt;1−ヒドロキシベンゾトリアゾール PF( );PFは保護されたアミノ酸またはペプチド
フラグメントを意味し、( )内の数字は式〔I〕のア
ミノ酸の順序を示す。
The abbreviations used in this specification have the following meanings. Ser; L-serine Val; L-valine Glu; L-glutamic acid Ile; L-isoleucine Gln; L-glutamine Leu; L-leucine Nle; L-norleucine His; L-histidine Asn; L-asparagine Gly; glycine Lys; L-lysine Arg; L-arginine Trp; L-tryptophan Asp; L-aspartic acid Tyr; L-tyrosine Boc; t-butyloxycarbonyl Aoc; t-amyloxycarbonyl Z-Cl; o-chlorobenzyloxycarbonyl Bzl; benzyl Bzl-Cl 2; 2,6- dichlorobenzyl Tos; tosyl OEt; ethyl ester OBzl; benzyl ester ONP; p-nitrophenyl ester OPAC; Hue None ester TFA; trifluoroacetic acid TosO ; P-toluenesulfonic acid Et 3 N; Triethylamine NMM; N-methylmorpholine TBA; t-butylamine DCHA; dicyclohexylamine NaOH; sodium hydroxide THF; tetrahydrofuran DMF; dimethylformamide DMSO; dimethyl sulfoxide ether diethyl ether DCC; N, N′-dicyclohexylcarbodiimide WSC; N-ethyl, N′-3-dimethylaminopropyl-carbodiimide HOBt; 1-hydroxybenzotriazole PF (); PF means a protected amino acid or peptide fragment, and the number in parentheses Represents the order of amino acids of formula [I].

【0032】[0032]

【参考例】次に参考例および実施例を挙げて本発明の製
造例を具体的に説明する。尚、実施例で使用した薄層ク
ロマトグラフイー(TLC)の担体および展開溶媒系な
らびにアミノ酸の分析の条件は次の通りである。 <TLC> 担体;シリカゲルG 展開溶媒系; 1.クロロホルム−メタノール−酢酸(95:5:
3)、 2.クロロホルム−メタノール−酢酸(85:15:
5)、 3.クロロホルム−メタノール−酢酸(80:25:
2)、 4.クロロホルム−エタノール−酢酸エチル(5:2:
5)、 5.ヘキサン−酢酸エチル(1:1) 担体;セルロース(メルク社製,DC−Alufoli
en) 展開溶媒系; 6.ブタノール−ピリジン−酢酸−水(5:3:0.
1:11)の上層 <アミノ酸分析>特記しない限り、試料は6N塩酸で1
10℃、24〜48時間封管中で加水分解した。
Reference Example Next, a production example of the present invention will be specifically described with reference to Reference Examples and Examples. The conditions for the carrier and developing solvent system of thin layer chromatography (TLC) used in the examples and the analysis of amino acids are as follows. <TLC>carrier; silica gel G developing solvent system; Chloroform-methanol-acetic acid (95: 5:
3), 2. Chloroform-methanol-acetic acid (85:15:
5), 3. Chloroform-methanol-acetic acid (80:25:
2), 4. Chloroform-ethanol-ethyl acetate (5: 2:
5), 5. Hexane-ethyl acetate (1: 1) Carrier: Cellulose (manufactured by Merck, DC-Alufoli
en) Developing solvent system; Butanol-pyridine-acetic acid-water (5: 3: 0.
1:11) Upper layer <Amino acid analysis> Unless otherwise specified, the sample was 1N with 6N hydrochloric acid.
Hydrolysis was performed in a sealed tube at 10 ° C. for 24 to 48 hours.

【0033】参考例1 〔Nle8 ,Nle18,Tyr34〕−h−PTH(1−
34)NH2 の製造 1)PF(34);Boc−Tyr(Bzl−Cl2
−NH2〔1〕 Boc−Tyr(Bzl−Cl2 )−OH52.84g
(0.12M)とp−ニトロフエノール16.69g
(0.12M)を乾燥THFに溶かし、これに−5℃で
冷却下DCC24.76g(0.12M)の乾燥THF
溶液を滴下した後、一夜攪拌した。反応後、析出物を濾
去し、濾液にNH3 ガスを飽和し、5時間攪拌した。沈
澱物が生じるが、DMFを加えて溶解した後、減圧濃縮
した。残渣をエーテルから結晶化した後、濾取、乾燥し
て目的物〔1〕を得た。 収量;44.77g(収率84.9%)、融点;214
〜216℃ TLC;Rf1 =0.62 〔α〕25D−5.54°(C=1,DMF)
Reference Example 1 [Nle 8 , Nle 18 , Tyr 34 ] -h-PTH (1-
34) Preparation of NH 2 1) PF (34) ; Boc-Tyr (Bzl-Cl 2)
-NH 2 (1) Boc-Tyr (Bzl-Cl 2 ) -OH52.84g
(0.12M) and 16.69 g of p-nitrophenol
(0.12M) was dissolved in dry THF, and 24.76g (0.12M) dry THF of DCC was added thereto while cooling at -5 ° C.
After the solution was added dropwise, the mixture was stirred overnight. After the reaction, the precipitate was filtered off, the filtrate was saturated with NH 3 gas, and the mixture was stirred for 5 hours. Although a precipitate was formed, DMF was added and dissolved, and then concentrated under reduced pressure. The residue was crystallized from ether, collected by filtration and dried to obtain the target product [1]. Yield: 44.77 g (yield 84.9%), melting point: 214
˜216 ° C. TLC; Rf 1 = 0.62 [Α] 25 D-5.54 ° (C = 1, DMF)

【0034】2)PF(33−34);Boc−Asn
−Tyr(Bzl−Cl2 )−NH2 〔2〕 化合物〔1〕26.36g(60mM)を塩化メチレン
に溶かし、これに氷冷下TFA100mlを加えた後、室
温で30分間攪拌した。反応後、塩化メチレンとTFA
を減圧留去し、残渣をエーテルで結晶化した後、濾取
し、乾燥した。得られた結晶、Boc−Asn−OH1
3.93g(60mM)およびHOBt8.1g(60
mM)をDMFに溶かし、これに−15℃で冷却下WS
C10.98ml(60mM)を加えた後、一夜攪拌し
た。反応後、沈澱物を濾取し、5%重曹水(1回)、水
(2回)、メタノール(1回)の順で洗浄し、乾燥して
目的物〔2〕の結晶を得た。母液は減圧下DMFを留去
し、得られた結晶を水、メタノールの順で洗浄し、乾燥
して化合物〔2〕を得、先の目的物〔2〕と合わせた。 収量;28.64g(収率86.25%)、融点;24
0〜242℃ 〔α〕25D−24.06°(C=1,DMF)
2) PF (33-34); Boc-Asn
Dissolved -Tyr the (Bzl-Cl 2) -NH 2 (2) Compound (1) 26.36g (60mM) in methylene chloride, after adding ice-cooling TFA100ml thereto, followed by stirring at room temperature for 30 minutes. After the reaction, methylene chloride and TFA
Was distilled off under reduced pressure, and the residue was crystallized with ether, collected by filtration and dried. Obtained crystals, Boc-Asn-OH1
3.93 g (60 mM) and HOBt 8.1 g (60
(mM) in DMF and WS at -15 ° C under cooling
After adding 10.98 ml (60 mM) of C, the mixture was stirred overnight. After the reaction, the precipitate was collected by filtration, washed with 5% aqueous sodium hydrogen carbonate (once), water (twice), and methanol (once) in that order, and dried to obtain crystals of the target product [2]. DMF was distilled off from the mother liquor under reduced pressure, and the obtained crystals were washed with water and methanol in this order and dried to obtain a compound [2], which was combined with the target compound [2]. Yield: 28.64 g (86.25% yield), melting point: 24
0-242 ° C [α] 25 D-24.06 ° (C = 1, DMF)

【0035】3)PF(32−34);Boc−His
(Tos)−Asn−Tyr(Bzl−Cl2 )−NH
2 〔3〕 化合物〔2〕22.14g(40mM)を少量の塩化メ
チレンに溶かし、これに氷冷下TFA100mlを加え、
室温で30分間攪拌した。TFAを減圧下留去して脱B
oc化物を得た。一方、Boc−His(Tos)−O
H・DCHA28.36g(48mM)を酢酸エチル5
00mlに懸濁し、1N硫酸で2回、水で2回の順に洗浄
し、無水芒硝で乾燥した後、減圧下酢酸エチルを留去し
た。残渣を乾燥DMFに溶かし、これに前記の脱Boc
化物の乾燥DMF溶液およびHOBt6.48g(48
mM)を加え、次いで−15℃で冷却下WSC8.78
ml(48mM)を加えた後、室温で一夜攪拌した。反応
後、減圧下DMFを留去し、残渣を5%重曹水で1回、
水で2回の順に洗浄した後、乾燥して粗生成物を得た。
これをメタノール−エーテルから結晶化して目的物
〔3〕を得た。結晶母液を減圧濃縮し、残渣をメタノー
ル−ヘキサンから結晶化して化合物〔3〕を得、先の目
的物〔3〕と合わせた。 収量;28.81g(収率85.1%)、融点;170
〜175℃ TLC;Rf3 =0.68、0.42 一部Tosが脱離したものが得られた。
3) PF (32-34); Boc-His
(Tos) -Asn-Tyr (Bzl -Cl 2) -NH
2 [3] 22.14 g (40 mM) of the compound [2] was dissolved in a small amount of methylene chloride, and 100 ml of TFA was added thereto under ice cooling,
Stir for 30 minutes at room temperature. TFA was distilled off under reduced pressure to remove B.
oc compound was obtained. On the other hand, Boc-His (Tos) -O
28.36 g (48 mM) of H-DCHA was added to ethyl acetate 5
It was suspended in 00 ml, washed twice with 1N sulfuric acid and twice with water, dried over anhydrous sodium sulfate, and ethyl acetate was distilled off under reduced pressure. Dissolve the residue in dry DMF and add to it the de-Boc
DMF solution of compound and HOBt 6.48 g (48
mM), then WSC 8.78 under cooling at -15 ° C.
After adding ml (48 mM), the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was washed once with 5% aqueous sodium hydrogen carbonate,
It was washed with water twice in this order and then dried to obtain a crude product.
This was crystallized from methanol-ether to obtain the desired product [3]. The crystal mother liquor was concentrated under reduced pressure, and the residue was crystallized from methanol-hexane to obtain the compound [3], which was combined with the target compound [3]. Yield: 28.81 g (yield 85.1%), melting point: 170
˜175 ° C. TLC; Rf 3 = 0.68, 0.42 Some Tos desorbed was obtained.

【0036】4)PF(31−34);Boc−配列番
号:2−NH2 〔4〕 化合物〔3〕28.81g(34.06mM)を少量の
塩化メチレンに溶かし、これに氷冷下TFA120mlを
加え、室温で30分間攪拌した後、TFAを減圧下留去
した。残渣にエーテルを加え、析出した結晶を濾取、乾
燥後、DMF140mlに溶解した。この溶液をNMMで
中和し、これにBoc−Val−OH8.14g(3
7.47mM)およびHOBt5.06g(37.47
mM)を、乾燥DMF60mlに溶解した溶液を加え、次
いで−15℃で冷却下WSC6.86ml(37.47m
M)を加え、室温で一夜攪拌した。反応後、減圧下DM
Fを留去し、残渣を5%重曹水で1回、水で3回洗浄
し、乾燥して目的物〔4〕を得た。 収量;27.76g(収率103.2%)、融点;16
4〜166℃ TLC;Rf3 =0.65 〔α〕25D−28.38°(C=1,DMF)
4) PF (31-34); Boc-SEQ ID NO: 2-NH 2 [4] 28.81 g (34.06 mM) of compound [3] was dissolved in a small amount of methylene chloride, and 120 ml of TFA was added thereto while cooling with ice. Was added and the mixture was stirred at room temperature for 30 minutes, and then TFA was distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected by filtration, dried and then dissolved in 140 ml of DMF. The solution was neutralized with NMM, and Boc-Val-OH (8.14 g, 3
7.47 mM) and HOBt 5.06 g (37.47)
(mM) was added to a solution of 60 ml of dry DMF, and then 6.86 ml (37.47 m) of WSC under cooling at -15 ° C.
M) was added and the mixture was stirred overnight at room temperature. After the reaction, DM under reduced pressure
F was distilled off, and the residue was washed once with a 5% aqueous sodium hydrogen carbonate solution and three times with water, and dried to obtain the target product [4]. Yield: 27.76 g (103.2% yield), melting point: 16
4 to 166 ° C. TLC; Rf 3 = 0.65 [α] 25 D−28.38 ° (C = 1, DMF)

【0037】5)PF(30−34);Boc−配列番
号:3−NH2 〔5〕 化合物〔4〕27.76g(35.15mM)を少量の
塩化メチレンに懸濁し、これに氷冷下TFA110mlを
加え、室温で30分間攪拌した後、TFAを減圧下留去
した。残渣にエーテルを加え、析出した結晶を濾取、乾
燥後、DMF120mlに溶解した。この溶液にNMM1
0mlを加えて中和し、これにBoc−Asp(OBz
l)−OH12.5g(38.67mM)およびHOB
t5.22g(38.67mM)を、乾燥DMF80ml
に溶解した溶液を加え、次いで−15℃で冷却下WSC
7.08ml(38.67mM)を加えた後、室温で一夜
攪拌した。反応後、減圧下DMFを留去し、残渣を5%
重曹水で1回、水で2回洗浄した後、メタノールに懸濁
してエーテルを加えて再結晶化して目的物〔5〕を得
た。 収量;31.42g(収率89.8%)、融点;214
〜215℃ TLC;Rf3 =0.6 〔α〕25D−23.28°(C=1,DMF)
5) PF (30-34); Boc-SEQ ID NO: 3-NH 2 [5] Compound [4] 27.76 g (35.15 mM) was suspended in a small amount of methylene chloride, and this was cooled on ice. After adding 110 ml of TFA and stirring at room temperature for 30 minutes, TFA was distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected by filtration, dried and then dissolved in 120 ml of DMF. NMM1 in this solution
0 ml was added to neutralize, and Boc-Asp (OBz
1) -OH 12.5 g (38.67 mM) and HOB
t5.22 g (38.67 mM) was added to dry DMF 80 ml.
Was added to the solution, then cooled at -15 ° C under WSC.
After adding 7.08 ml (38.67 mM), the mixture was stirred overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was 5%.
After washing once with aqueous sodium hydrogen carbonate and twice with water, the product was suspended in methanol and ether was added for recrystallization to obtain the desired product [5]. Yield: 31.42 g (yield 89.8%), melting point: 214
˜215 ° C. TLC; Rf 3 = 0.6 [α] 25 D-23.28 ° (C = 1, DMF)

【0038】6)PF(29−34);Boc−配列番
号:4−NH2 〔6〕 化合物〔5〕31.11g(31.27mM)を塩化メ
チレンに懸濁し、これに氷冷下TFA120mlを加え、
室温で30分間攪拌した後、TFA、塩化メチレンを減
圧下留去した。残渣にエーテルを加え、析出した結晶を
濾取、乾燥後、乾燥DMF100mlに溶解した。この溶
液をNMM8mlで中和し、これにBoc−Gln−ON
P12.64g(34.4mM)およびHOBt0.4
2g(3.13mM)を、乾燥DMF100mlに溶解し
た溶液を加え、次いで氷冷下NMM3.78mlを加えた
後、一夜攪拌した。反応後、減圧下DMFを留去し、残
渣を5%重曹水で1回、水で2回洗浄した後、メタノー
ルに懸濁し、エーテルで再結晶化して目的物〔6〕を得
た。 収量;33.19g(収率94.5%)、融点;81〜
83℃ TLC;Rf3 =0.47 〔α〕24D−23.98°(C=1,DMF) アミノ酸分析;Asp2.19(2)、Glu1.05
(1)、Val1(1)、Tyr0.73(1)、Hi
s0.85(1)
6) PF (29-34); Boc-SEQ ID NO: 4-NH 2 [6] 31.11 g (31.27 mM) of compound [5] compound [5] was suspended in methylene chloride, and 120 ml of TFA was added thereto while cooling with ice. In addition,
After stirring at room temperature for 30 minutes, TFA and methylene chloride were distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected by filtration, dried and then dissolved in 100 ml of dry DMF. This solution was neutralized with 8 ml of NMM, and Boc-Gln-ON was added to it.
P12.64 g (34.4 mM) and HOBt0.4
A solution prepared by dissolving 2 g (3.13 mM) in 100 ml of dry DMF was added, and then 3.78 ml of NMM was added under ice cooling, followed by stirring overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was washed once with a 5% aqueous sodium hydrogen carbonate solution and twice with water, then suspended in methanol and recrystallized with ether to obtain the target compound [6]. Yield: 33.19 g (yield 94.5%), melting point: 81-
83 ° C. TLC; Rf 3 = 0.47 [α] 24 D-23.98 ° (C = 1, DMF) Amino acid analysis; Asp2.19 (2), Glu1.05
(1), Val1 (1), Tyr0.73 (1), Hi
s0.85 (1)

【0039】7)PF(27−28);Boc−Lys
(Z−Cl)−Leu−OEt〔7〕 Boc−Lys(Z−Cl)−OH・TBA97.6g
(0.2M)を酢酸エチル500mlに懸濁し、これを1
N塩酸、水の順で洗浄し、無水芒硝で乾燥した後、減圧
濃縮して油状物を得た。これを乾燥THF500mlに溶
かし、これにH−Leu−OEt・HCl39.14g
(0.2M)およびHOBt27.0g(0.2M)を
加え、次いで−15℃に冷却下WSC36.6ml(0.
2M)を加えた後、室温で一夜攪拌した。反応後、減圧
下THFを留去した。残渣を酢酸エチル600mlに溶か
し、5%重曹水、水、1N塩酸、水の順で洗浄し、無水
芒硝で乾燥後、減圧濃縮した。残渣を冷所で放置して結
晶化させた。ヘキサンを加えて濾取して目的物〔7〕を
得た。 収量;110.62g(収率99.5%)、融点;77
〜80℃ TLC;Rf3 =0.48 〔α〕24D−19.08°(C=1,DMF)
7) PF (27-28); Boc-Lys
(Z-Cl) -Leu-OEt [7] Boc-Lys (Z-Cl) -OH.TBA 97.6 g
(0.2 M) was suspended in 500 ml of ethyl acetate, and this was added to 1
The mixture was washed with N hydrochloric acid and water in this order, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give an oil. This was dissolved in 500 ml of dry THF, and 39.14 g of H-Leu-OEt.HCl was added thereto.
(0.2 M) and 27.0 g (0.2 M) HOBt were added, then 36.6 ml (0.
2M) was added, and the mixture was stirred overnight at room temperature. After the reaction, THF was distilled off under reduced pressure. The residue was dissolved in 600 ml of ethyl acetate, washed with 5% aqueous sodium hydrogen carbonate, water, 1N hydrochloric acid and water in this order, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was left to crystallize in the cold. Hexane was added and the product was collected by filtration to obtain the desired product [7]. Yield: 110.62 g (yield 99.5%), melting point: 77
~80 ℃ TLC; Rf 3 = 0.48 [α] 24 D-19.08 ° (C = 1, DMF)

【0040】8)PF(26−28);Boc−Lys
(Z−Cl)−Lys(Z−Cl)−Leu−OEt
〔8〕 化合物〔7〕110.62g(0.199M)を塩化メ
チレン50mlに加え、これに氷冷下TFA250mlを加
えた後、室温で1時間攪拌した。反応後、減圧下TF
A、塩化メチレンを留去して油状の脱Boc化物を得
た。
8) PF (26-28); Boc-Lys
(Z-Cl) -Lys (Z-Cl) -Leu-OEt
[8] The compound [7] 110.62 g (0.199 M) was added to 50 ml of methylene chloride, 250 ml of TFA was added thereto under ice cooling, and the mixture was stirred at room temperature for 1 hour. After the reaction, TF under reduced pressure
A and methylene chloride were distilled off to obtain an oily de-Boc product.

【0041】一方、Boc−Lys(Z−Cl)−OH
・TBA97.1g(0.199M)を酢酸エチル50
0mlに懸濁し、1N塩酸300ml、水の順で洗浄し、無
水芒硝で乾燥後、減圧濃縮して油状物を得る。これを乾
燥THF150mlに溶かし、これに前記の脱Boc化物
およびHOBt26.9g(0.199M)を乾燥TH
F250mlに溶解した溶液を加え、次いで−15℃に冷
却下WSC36.4ml(0.199M)を滴下した後、
室温で一夜攪拌した。反応後、THFを減圧留去すると
寒天状結晶が析出した。これを酢酸エチルに溶かし、5
%重曹水、水、1N塩酸、水の順に洗浄し、無水芒硝で
乾燥後、減圧濃縮した。生じた沈澱物をヘキサンで処理
した後、濾取した。これを酢酸エチル、エーテル、ヘキ
サンから再結晶して目的物〔8〕を得た。 収量;156.52g(収率92.2%)、融点;11
4〜116℃ TLC;Rf2 =0.78 〔α〕29D−20.72°(C=1,DMF)
On the other hand, Boc-Lys (Z-Cl) -OH
-TBA 97.1 g (0.199 M) was added to ethyl acetate 50
The product was suspended in 0 ml, washed with 300 ml of 1N hydrochloric acid and water in this order, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give an oil. This was dissolved in 150 ml of dry THF, and 26.9 g (0.199M) of the above-mentioned de-Boc product and HOBt was dried in TH.
After adding a solution dissolved in 250 ml of F, 36.4 ml (0.199M) of WSC was added dropwise while cooling to -15 ° C.
Stir overnight at room temperature. After the reaction, THF was distilled off under reduced pressure to precipitate agar crystals. Dissolve this in ethyl acetate, 5
% Sodium bicarbonate water, water, 1N hydrochloric acid, water in this order, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting precipitate was treated with hexane and collected by filtration. This was recrystallized from ethyl acetate, ether and hexane to obtain the desired product [8]. Yield: 156.52 g (yield 92.2%), melting point: 11
4 to 116 ° C. TLC; Rf 2 = 0.78 [α] 29 D-20.72 ° (C = 1, DMF)

【0042】9)PF(25−28);Aoc−配列番
号:5−OEt
9) PF (25-28); Aoc-SEQ ID NO: 5-OEt

〔9〕 化合物〔8〕156.5g(184mM)を塩化メチレ
ン50mlに加え、これに氷冷下TFA250mlを加えた
後、室温で1時間攪拌した。反応液を減圧濃縮し、残渣
を乾燥DMF300mlに溶かした後、NMMで中和し
た、これにAoc−Arg(Tos)−OH86.0g
(202mM)を乾燥DMF100mlに溶解した溶液お
よびHOBt27.3g(202mM)を加え、次いで
−15℃に冷却下WSC37.0ml(202mM)を滴
下した後、室温で一夜攪拌した。反応後、DMFを減圧
留去し、残渣を酢酸エチル1lに溶解した。この溶液を
5%重曹水で2回、飽和食塩水、1N塩酸で2回、飽和
食塩水の順で洗浄し、無水芒硝で乾燥後、減圧濃縮し
た。残渣にエーテルを加え、濾取して目的物
[9] 156.5 g (184 mM) of the compound [8] was added to 50 ml of methylene chloride, 250 ml of TFA was added thereto under ice cooling, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, the residue was dissolved in 300 ml of dry DMF and then neutralized with NMM, and 86.0 g of Aoc-Arg (Tos) -OH was added thereto.
A solution prepared by dissolving (202 mM) in 100 ml of dry DMF and 27.3 g (202 mM) of HOBt were added, and then 37.0 ml (202 mM) of WSC was added dropwise under cooling to -15 ° C, followed by stirring at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 1 l of ethyl acetate. This solution was washed twice with a 5% aqueous sodium hydrogen carbonate solution, twice with a saturated saline solution and twice with a 1N hydrochloric acid solution, and then saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. Ether is added to the residue and filtered to obtain the desired product.

〔9〕を得
た。 収量;217.91g(収率100.6%)、融点;7
5〜78℃ TLC;Rf1 =0.09、Rf2 =0.67 〔α〕28D−14.02°(C=1,DMF)
[9] was obtained. Yield: 217.91 g (100.6% yield), melting point; 7
5 to 78 ° C. TLC; Rf 1 = 0.09, Rf 2 = 0.67 [α] 28 D-14.02 ° (C = 1, DMF)

【0043】10)PF(24−28);Boc−配列
番号:6−OEt〔10〕 化合物
10) PF (24-28); Boc-SEQ ID NO: 6-OEt [10] compound

〔9〕217.9g(0.185M)に塩化メチ
レン100mlおよびTFA250mlを加え、室温で80
分間攪拌した後、減圧下塩化メチレンおよびTFAを留
去した。得られた油状物を乾燥DMF300mlに溶か
し、NMMを加えて中和した。この溶液にBoc−Le
u−OH・H2 O50.9g(0.204M)およびH
OBt27.6g(0.204M)を乾燥DMF100
mlに溶解した溶液を加え、次いで−15℃で冷却下WS
C37.3ml(0.204M)を滴下した後、室温で一
夜攪拌した。反応後、減圧下DMFを留去し、残渣を水
に加え、析出した生成物を濾取した。メタノール−エー
テル−ヘキサンから2回再結晶化して目的物〔10〕を
得た。 収量;213.63g(収率90.5%)、融点;15
7〜160℃ TLC;Rf1 =0.28、Rf2 =0.77 〔α〕27D−18.68°(C=1,DMF)
[9] To 217.9 g (0.185 M), add 100 ml of methylene chloride and 250 ml of TFA, and add 80 at room temperature.
After stirring for 1 minute, methylene chloride and TFA were distilled off under reduced pressure. The obtained oily substance was dissolved in 300 ml of dry DMF, and NMM was added for neutralization. Boc-Le in this solution
u-OH.H 2 O 50.9 g (0.204 M) and H
27.6 g (0.204 M) of OBt was added to dry DMF100.
Add the solution dissolved in ml, then cool at -15 ° C WS
C37.3 ml (0.204M) was added dropwise, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was added to water, and the precipitated product was collected by filtration. Recrystallization from methanol-ether-hexane twice gave the target product [10]. Yield: 213.63 g (90.5% yield), melting point: 15
7 to 160 ° C. TLC; Rf 1 = 0.28, Rf 2 = 0.77 [α] 27 D-18.68 ° (C = 1, DMF)

【0044】11)PF(23−28);Boc−配列
番号:7−OEt〔11〕 化合物〔10〕153.17g(0.12M)に塩化メ
チレン100mlおよびTFA250mlを加え、室温で8
0分間攪拌した後、減圧下塩化メチレンおよびTFAを
留去した。残渣を乾燥DMF250mlに溶かし、NMM
でpHに中和した。この溶液にHOBt17.84g
(0.132M)とBoc−Trp−OH40.17g
(0.132M)を加え、次いで−15℃で冷却下、W
SC24.2ml(0.132M)を滴下した後、室温で
一夜攪拌した。反応後、減圧下DMFを留去し、残渣を
5%重曹水5lに注ぎ、析出した生成物を濾取した。こ
れを水に懸濁して濾取した後、メタノール−エーテルか
ら2回再結晶化して目的物〔11〕を得た。 収量;142.57g(収率81.2%)、融点;16
8〜170℃ TLC;Rf1 =0.31、Rf2 =0.82 〔α〕28D−18.64°(C=1,DMF)
11) PF (23-28); Boc-SEQ ID NO: 7-OEt [11] To 153.17 g (0.12 M) of compound [10], 100 ml of methylene chloride and 250 ml of TFA were added, and the mixture was allowed to stand at room temperature for 8 hours.
After stirring for 0 minutes, methylene chloride and TFA were distilled off under reduced pressure. The residue is dissolved in 250 ml of dry DMF and NMM is added.
Neutralized to pH. HOBt 17.84g in this solution
(0.132M) and Boc-Trp-OH 40.17g
(0.132M), then cooled to -15 ° C under W
After adding 24.2 ml (0.132M) of SC dropwise, the mixture was stirred overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, the residue was poured into 5 L of 5% aqueous sodium hydrogen carbonate, and the precipitated product was collected by filtration. This was suspended in water, collected by filtration, and recrystallized twice from methanol-ether to obtain the desired product [11]. Yield: 142.57 g (81.2% yield), melting point: 16
8 to 170 ° C. TLC; Rf 1 = 0.31, Rf 2 = 0.82 [α] 28 D-18.64 ° (C = 1, DMF)

【0045】12)PF(23−28);Boc−配列
番号:7−OH〔12〕 化合物〔11〕140.64g(96.16mM)を熱
エタノール1200mlに溶解し、冷却後、少量の析出物
を濾別した後、1N−NaOH水溶液288ml(3倍
M)を加え、室温で1時間攪拌した。反応液に1N−T
osOH水溶液192ml(2倍M)を加えた後、濾別
し、エタノールを減圧留去した。濃縮液に1N−Tos
OH96ml(等M)を加え、次いで水2lを加えた後、
生じた沈澱物を濾取した。水で2回洗浄した後、乾燥し
て目的物〔12〕を得た。 収量;142.98g(収率101.1%) 融点;125〜130℃ TLC;Rf2 =0.71 〔α〕27D−37.24°(C=1,DMF) アミノ酸分析;Leu2(2)、Lys2.08
(2)、Arg1.10(1)、Trp0.83(1)
12) PF (23-28); Boc-SEQ ID NO: 7-OH [12] Compound [11] 140.64 g (96.16 mM) was dissolved in 1200 ml of hot ethanol, and after cooling, a small amount of precipitate Was filtered off, 288 ml of 1N-NaOH aqueous solution (3 times M) was added, and the mixture was stirred at room temperature for 1 hour. 1N-T in the reaction solution
After adding 192 ml of an osOH aqueous solution (2 times M), the mixture was filtered and ethanol was distilled off under reduced pressure. 1N-Tos for concentrated liquid
After adding 96 ml of OH (equal to M) and then 2 l of water,
The resulting precipitate was collected by filtration. After washing twice with water, it was dried to obtain the desired product [12]. Yield: 142.98 g (yield 101.1%) Melting point: 125 to 130 ° C. TLC; Rf 2 = 0.71 [α] 27 D-37.24 ° (C = 1, DMF) Amino acid analysis; Leu2 (2), Lys2.08
(2), Arg1.10 (1), Trp0.83 (1)

【0046】13)PF(23−34);Boc−配列
番号:8−NH2 〔13〕 化合物〔6〕1.68g(1.5mM)を少量の塩化メ
チレンに懸濁し、次いで氷冷下TFA7mlを加えた後、
室温で30分間攪拌した。反応後、減圧下TFAを留去
し、残渣にエーテルを加え、析出した結晶を濾取、乾燥
した。この結晶を乾燥DMF30mlに溶かし、少量のN
MMで中和した。この溶液に化合物〔12〕2.43g
(1.65mM)、HOBt0.22g(1.65m
M)および乾燥DMF20mlを加え、次いで−15℃で
冷却下WSC0.3ml(1.1倍M)を加えた後、室温
で一夜攪拌した。反応後、減圧下DMFを留去し、残渣
を5%重曹水で1回、水で2回洗浄した後、メタノール
に懸濁し、エーテルを加え、濾取、乾燥して目的物〔1
3〕を得た。 収量;3.62g(収率99.1%)、融点;260〜
270℃ 〔α〕25D−4.66°(C=0.3,DMF) アミノ酸分析;Asp1.94(2)、Glu0.96
(1)、Val0.71(1)、Leu2.00
(2)、Tyr0.98(1)、Lys2.09
(2)、His0.58(1)、Arg0.91
(1)、Trp0.78(1)
13) PF (23-34); Boc-SEQ ID NO: 8-NH 2 [13] 1.68 g (1.5 mM) of the compound [6] was suspended in a small amount of methylene chloride, and then 7 ml of TFA under ice cooling. After adding
Stir for 30 minutes at room temperature. After the reaction, TFA was distilled off under reduced pressure, ether was added to the residue, and the precipitated crystals were collected by filtration and dried. The crystals were dissolved in 30 ml of dry DMF and a small amount of N was added.
Neutralized with MM. 2.43 g of compound [12] in this solution
(1.65 mM), HOBt 0.22 g (1.65 m)
M) and 20 ml of dry DMF were added, and then 0.3 ml of WSC (1.1 times M) was added under cooling at -15 ° C, followed by stirring at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was washed once with a 5% aqueous sodium hydrogen carbonate solution and twice with water, suspended in methanol, added with ether, filtered and dried to obtain the desired product [1
3] was obtained. Yield: 3.62 g (99.1% yield), melting point: 260-
270 ° C. [α] 25 D-4.66 ° (C = 0.3, DMF) amino acid analysis; Asp1.94 (2), Glu0.96
(1), Val0.71 (1), Leu2.00
(2), Tyr0.98 (1), Lys2.09
(2), His0.58 (1), Arg0.91
(1), Trp0.78 (1)

【0047】14)PF(22);Boc−Glu(O
Bzl)−OPAC〔14〕 Boc−Glu(OBzl)−OH128.2g(0.
38M)をDMF600mlに溶かし、これに氷冷下フエ
ナシルブロマイド113.5g(0.57M)を加えた
後、Et3 N79.3ml(0.57M)を滴下した。滴
下後、30℃で4時間攪拌し、次いで酢酸カリウム30
gを加え、45分間攪拌した後、減圧下DMFを留去し
た。残渣に酢酸エチル600mlを加え、5%重曹水で2
回、水で2回洗浄し、酢酸エチル層を無水芒硝で乾燥
後、減圧下溶媒を留去すると、結晶が析出した。これに
ヘキサンを加え、濾取して目的物〔14〕を得た。 収量;156.19g(収率90.2%) TLC;Rf5 =0.73
14) PF (22); Boc-Glu (O
Bzl) -OPAC [14] Boc-Glu (OBzl) -OH 128.2 g (0.
38M) was dissolved in 600 ml of DMF, 113.5 g (0.57M) of phenacyl bromide was added thereto under ice cooling, and then 79.3 ml (0.57M) of Et 3 N was added dropwise. After dropping, the mixture was stirred at 30 ° C. for 4 hours, and then potassium acetate 30
After adding g, and stirring for 45 minutes, DMF was distilled off under reduced pressure. Add 600 ml of ethyl acetate to the residue and add 2 with 5% aqueous sodium hydrogen carbonate.
After washing twice with water and twice with water, the ethyl acetate layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to precipitate crystals. Hexane was added to this and the product was collected by filtration to obtain the desired product [14]. Yield: 156.19 g (yield 90.2%) TLC; Rf 5 = 0.73

【0048】15)PF(21−22);Boc−Va
l−Glu(OBzl)−OPAC〔15〕 化合物〔14〕147.88g(0.325M)に塩化
メチレン50mlを加え、これに氷冷下TFA300mlを
加え、室温で1時間攪拌した後、減圧下で塩化メチレン
およびTFAを留去した。残渣にエーテルを加え、析出
した結晶を濾取、乾燥した。この結晶を乾燥DMF30
0mlに溶解し、NMMでpH7に中和した。この溶液に
HOBt35.14g(0.26M)およびBoc−V
al−OH56.49g(0.26M)を加え、−15
℃で冷却下WSC47.6ml(0.26M)を滴下した
後、室温で2日間攪拌した。反応後、減圧下でDMFを
留去し、残渣をクロロホルム500mlに溶かし、5%重
曹水、水、1N塩酸、水の順で洗浄した。クロロホルム
層を無水芒硝で乾燥し、減圧下溶媒を留去し、得られた
結晶にヘキサンを加えて濾取した後、酢酸エチル−エー
テルより再結晶化して目的物〔15〕を得た。 収量;106.97g(収率74.2%)、融点;13
9〜141℃ TLC;Rf3 =0.63 〔α〕29D−18.92°(C=1,DMF)
15) PF (21-22); Boc-Va
l-Glu (OBzl) -OPAC [15] To 147.88 g (0.325M) of the compound [14], 50 ml of methylene chloride was added, 300 ml of TFA was added thereto under ice cooling, and the mixture was stirred at room temperature for 1 hour and then under reduced pressure. Methylene chloride and TFA were distilled off. Ether was added to the residue, and the precipitated crystals were collected by filtration and dried. This crystal was dried with DMF30.
It was dissolved in 0 ml and neutralized to pH 7 with NMM. 35.14 g (0.26 M) of HOBt and Boc-V were added to this solution.
56.49 g (0.26M) of al-OH was added, and -15
After adding 47.6 ml (0.26M) of WSC under cooling at ℃, the mixture was stirred at room temperature for 2 days. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in 500 ml of chloroform, and washed with 5% aqueous sodium hydrogen carbonate, water, 1N hydrochloric acid and water in this order. The chloroform layer was dried over anhydrous sodium sulfate, the solvent was evaporated under reduced pressure, hexane was added to the obtained crystals, and the crystals were collected by filtration and then recrystallized from ethyl acetate-ether to obtain the desired product [15]. Yield: 106.97 g (74.2% yield), melting point: 13
9 to 141 ° C. TLC; Rf 3 = 0.63 [α] 29 D-18.92 ° (C = 1, DMF)

【0049】16)PF(20−22);Aoc−Ar
g(Tos)−Val−Glu(OBzl)−OPAC
〔16〕 化合物〔15〕99.83g(0.18M)に塩化メチ
レン50mlを加え、これに氷冷下TFA200mlを加
え、室温で1時間攪拌した後、減圧下で塩化メチレンお
よびTFAを留去した。残渣にヘキサンを加えて処理
し、傾斜法によりヘキサンを除去した後、エーテルを加
えて処理した後、減圧下でエーテルを留去した。得られ
た油状物を乾燥DMF200mlに溶かし、NMMで中和
した。この溶液にHOBt24.33g(0.18
M)、Aoc−Arg(Tos)−OH76.60g
(0.18M)および乾燥DMF200mlを加え、これ
に−15℃で冷却下WSC32.94ml(0.18M)
を滴下した後、室温で一夜攪拌した。反応後、減圧下で
DMFを留去し、残渣を酢酸エチル1lに溶解した。こ
の溶液を5%重曹水、水、1N塩酸、水の順で洗浄し、
無水芒硝で乾燥後、減圧下酢酸エチルを留去した。得ら
れた油状物を酢酸エチル−エーテルにより結晶化し、得
られた結晶をエーテルに懸濁して濾取する工程を3回行
って目的物〔16〕を得た。 収量;149.75g(収率94.6%)、融点;11
0〜114℃ TLC;Rf1 =0.74、Rf4 =0.81 〔α〕29D−11.5°(C=1,DMF)
16) PF (20-22); Aoc-Ar
g (Tos) -Val-Glu (OBzl) -OPAC
[16] To 99.83 g (0.18 M) of the compound [15], 50 ml of methylene chloride was added, 200 ml of TFA was added thereto under ice cooling, and the mixture was stirred at room temperature for 1 hour, and then methylene chloride and TFA were distilled off under reduced pressure. . Hexane was added to the residue for treatment, the hexane was removed by a gradient method, ether was added for treatment, and then ether was distilled off under reduced pressure. The oil obtained was dissolved in 200 ml of dry DMF and neutralized with NMM. 24.33 g (0.18 g) of HOBt was added to this solution.
M), Aoc-Arg (Tos) -OH 76.60g
(0.18M) and 200 ml of dry DMF were added, and 32.94 ml (0.18M) of WSC under cooling at -15 ° C.
Was added dropwise, and the mixture was stirred overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 1 l of ethyl acetate. This solution was washed with 5% aqueous sodium hydrogen carbonate, water, 1N hydrochloric acid, and water in this order,
After drying over anhydrous sodium sulfate, ethyl acetate was distilled off under reduced pressure. The obtained oily substance was crystallized from ethyl acetate-ether, and the obtained crystals were suspended in ether and collected by filtration three times to obtain the desired product [16]. Yield: 149.75 g (94.6% yield), melting point: 11
0 to 114 ° C. TLC; Rf 1 = 0.74, Rf 4 = 0.81 [α] 29 D-11.5 ° (C = 1, DMF)

【0050】17)PF(19−22);Boc−配列
番号:9−OPAC〔17〕 化合物〔16〕149.40g(0.17M)に塩化メ
チレン50mlを加え、これに氷冷下TFA300mlを加
え、室温で1時間攪拌した後、減圧下で塩化メチレンお
よびTFAを留去した。残渣にエーテルを加えて処理
し、減圧下でエーテルを留去した後、得られた油状物を
乾燥DMF200mlに溶かした。これにHOBt25.
27g(0.187M)およびBoc−Glu(OBz
l)−OH63.09g(0.187M)を加え、乾燥
DMF100mlを追加し、−15℃で冷却下WSC3
4.22ml(0.187M)を加え、室温で一夜攪拌し
た。反応後、溶媒を留去し、残渣を水6lに注ぎ込み、
析出した結晶を濾取した。この結晶にメタノール−エー
テルを加えて懸濁して濾取し、熱メタノールに溶かし
て、冷時に析出化して濾取し、さらにメタノールに懸濁
して濾取する工程を3回行って化合物〔17〕を得た。
結晶母液から溶媒を留去し、メタノール−エーテルから
結晶化して目的物25.02gを得た。 収量;141.44g(収率76.7%)、融点;11
9〜121℃ TLC;Rf1 =0.56、Rf4 =0.82 〔α〕29D−12.9°(C=1,DMF)
17) PF (19-22); Boc-SEQ ID NO: 9-OPAC [17] Compound [16] 149.40 g (0.17 M) was added with 50 ml of methylene chloride, and 300 ml of TFA was added thereto under ice cooling. After stirring at room temperature for 1 hour, methylene chloride and TFA were distilled off under reduced pressure. Ether was added to the residue for treatment, the ether was distilled off under reduced pressure, and the obtained oily substance was dissolved in 200 ml of dry DMF. To this, HOBt25.
27g (0.187M) and Boc-Glu (OBz
l) -OH 63.09 g (0.187 M) was added, dry DMF 100 ml was added, and WSC3 under cooling at -15 ° C.
4.22 ml (0.187M) was added, and the mixture was stirred at room temperature overnight. After the reaction, the solvent was distilled off, the residue was poured into 6 l of water,
The precipitated crystals were collected by filtration. Methanol-ether was added to the crystals to suspend, and the crystals were collected by filtration, dissolved in hot methanol, precipitated when cold, collected by filtration, further suspended in methanol, and collected by filtration. Got
The solvent was distilled off from the crystal mother liquor, and the product was crystallized from methanol-ether to obtain 25.02 g of the desired product. Yield: 141.44 g (76.7% yield), melting point: 11
9 to 121 ° C. TLC; Rf 1 = 0.56, Rf 4 = 0.82 [α] 29 D-12.9 ° (C = 1, DMF)

【0051】18)PF(18−22);Boc−配列
番号:10−OPAC〔18〕 化合物〔17〕6.51g(6mM)に氷冷下塩化メチ
レンおよびTFA24mlを加え、室温で40分間攪拌し
た後、減圧下塩化メチレンおよびTFAを留去した。残
渣にエーテルを加えて結晶化し、乾燥した。この結晶を
乾燥DMFに溶かし、氷冷下NMMでpH7に中和し
た。この溶液にBoc−Nle−OH1.67g(7.
2mM)およびHOBt0.97g(7.2mM)を乾
燥DMF40mlに溶解した溶液を加え、−15℃に冷却
下WSC1.3ml(7.2mM)を加えた後、一夜攪拌
した。反応後、減圧下DMFを留去し、残渣に水を加
え、生じた沈澱物を濾取し、5%重曹水、水(3回)、
1N塩酸水(3回)、メタノールの順で洗浄した。次い
で、メタノール−エーテルから再沈澱を行い、目的物
〔18〕を得た。 収量;5.61g(収率78%)、TLC;Rf1
0.56
18) PF (18-22); Boc-SEQ ID NO: 10-OPAC [18] To 6.51 g (6 mM) of compound [17], methylene chloride and 24 ml of TFA were added under ice cooling, and the mixture was stirred at room temperature for 40 minutes. After that, methylene chloride and TFA were distilled off under reduced pressure. Ether was added to the residue to crystallize and dry. The crystals were dissolved in dry DMF and neutralized to pH 7 with NMM under ice cooling. 1.67 g of Boc-Nle-OH (7.
2mM) and 0.97g (7.2mM) of HOBt were dissolved in 40ml of dry DMF, 1.3ml (7.2mM) of WSC was added under cooling to -15 ° C, and then stirred overnight. After the reaction, DMF was distilled off under reduced pressure, water was added to the residue, the resulting precipitate was collected by filtration, and 5% aqueous sodium hydrogen carbonate solution, water (3 times),
The mixture was washed with 1N hydrochloric acid water (three times) and methanol in that order. Then, reprecipitation was carried out from methanol-ether to obtain the target product [18]. Yield: 5.61 g (78% yield), TLC; Rf 1 =
0.56

【0052】19)PF(18−22);Boc−配列
番号:10−OH〔19〕 化合物〔18〕5.03g(4.2mM)を酢酸30ml
に溶かし、これに亜鉛末8gを加え、室温で5.5時間
攪拌した。反応後、亜鉛末を濾去し、減圧下酢酸を留去
した。析出した結晶にエーテルを加え濾取して目的物
〔19〕を得た。 収量;4.42g、融点;210℃(分解) TLC;Rf1 =0.18、Rf2 =0.67 〔α〕27D−4.66°(C=0.3,DMF) アミノ酸分析;Nle1.01(1)、Glu2.05
(2)、Arg0.98(1)、Val1(1)
19) PF (18-22); Boc-SEQ ID NO: 10-OH [19] Compound [18] 5.03 g (4.2 mM) was added to acetic acid 30 ml.
8 g of zinc dust was added thereto, and the mixture was stirred at room temperature for 5.5 hours. After the reaction, zinc dust was filtered off, and acetic acid was distilled off under reduced pressure. Ether was added to the precipitated crystals and the crystals were collected by filtration to obtain the target product [19]. Yield; 4.42 g, melting point; 210 ° C. (decomposition) TLC; Rf 1 = 0.18, Rf 2 = 0.67 [α] 27 D-4.66 ° (C = 0.3, DMF) amino acid analysis; Nle1.01 (1), Glu2.05
(2), Arg0.98 (1), Val1 (1)

【0053】20)PF(18−34);Boc−配列
番号:11−NH2〔20〕 化合物〔13〕8.9g(3.5mM)にスカトール
0.5g(3.5mM)、ジメチルスフイド25ml、エ
タンジチオール2.5mlおよびTFA25mlを加え、0
℃で10分間、室温で45分間攪拌した後、反応液を減
圧濃縮した。残渣にエーテルを加え、生じた沈澱物を濾
取、乾燥した後、乾燥DMF100mlに溶かし、NMM
でpH7に中和した。この溶液にHOBt0.54g
(4mM)および化合物〔19〕4.3g(4mM)を
加え、−15℃に冷却下WSC0.73mlを加えた後、
室温で2日間攪拌した。反応後、減圧下DMFを留去
し、残渣に5%重曹水を加え、生じた沈澱物を濾取した
後、水で充分に洗浄した。この生成物をエタノールに溶
かし、エーテルを加えて沈澱化させる工程を2回行って
目的物〔20〕を得た。 収量;11.12g(収率94%)、融点;250℃
(分解) TLC;Rf3 =0.72 〔α〕28D−4.73°(C=0.53、DMF) アミノ酸分析;Asp1.98(2)、Glu3.04
(3)、Val1.69(2)、Leu2(2)、Ty
r1.07(1)、Lys1.93(2)、His0.
59(1)、Arg1.97(2)、Trp0.35
(1)、Nle1.07(1)
20) PF (18-34); Boc-SEQ ID NO: 11-NH 2 [20] Compound [13] 8.9 g (3.5 mM), skatole 0.5 g (3.5 mM), dimethyl sulfide. Add 25 ml, 2.5 ml ethanedithiol and 25 ml TFA,
After stirring at C for 10 minutes and at room temperature for 45 minutes, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected by filtration, dried, and dissolved in 100 ml of dry DMF to obtain NMM.
It was neutralized to pH 7 with. 0.54 g of HOBt in this solution
(4 mM) and compound [19] (4.3 g, 4 mM) were added, and WSC (0.73 ml) was added to the mixture at -15 ° C under cooling.
The mixture was stirred at room temperature for 2 days. After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium hydrogen carbonate was added to the residue, and the resulting precipitate was collected by filtration and washed thoroughly with water. The step of dissolving this product in ethanol and adding ether to precipitate the product was performed twice to obtain the target product [20]. Yield: 11.12 g (94% yield), melting point: 250 ° C.
(Decomposition) TLC; Rf 3 = 0.72 [α] 28 D-4.73 ° (C = 0.53, DMF) Amino acid analysis; Asp1.98 (2), Glu3.04
(3), Val 1.69 (2), Leu2 (2), Ty
r1.07 (1), Lys1.93 (2), His0.
59 (1), Arg1.97 (2), Trp0.35
(1), Nle 1.07 (1)

【0054】21)PF(17);Boc−Ser(B
zl)−OPAC〔21〕 Boc−Ser(Bzl)−OH88.6g(0.3
M)をDMF400mlに溶かし、これにフエナシルブロ
マイド89.6g(0.45M)を加え、これに氷冷下
Et3 N62.6ml(0.45M)を滴下した後、30
℃で3.5時間攪拌した。次いでこの反応液に酢酸カリ
ウム22.1g(0.225M)を加え、室温で1時間
攪拌した。反応後、減圧下DMFを留去し、残渣を酢酸
エチル500mlに溶かし、5%重量水、水の順で洗浄し
た。酢酸エチル層を無水芒硝で乾燥した後、減圧下溶媒
を留去した。残渣を冷蔵庫に放置して結晶化させ、ヘキ
サンを加え濾取して目的物〔21〕を得た。 収量;122.97g(収率99.1%)、融点;45
〜47℃ TLC;Rf5 =0.82 〔α〕29.5D−11.88°(C=1.0,DMF)
21) PF (17); Boc-Ser (B
zl) -OPAC [21] Boc-Ser (Bzl) -OH 88.6 g (0.3
M) was dissolved in 400 ml of DMF, 89.6 g (0.45M) of phenacyl bromide was added thereto, and 62.6 ml (0.45M) of Et 3 N was added dropwise thereto under ice cooling.
The mixture was stirred at ° C for 3.5 hours. Next, 22.1 g (0.225M) of potassium acetate was added to this reaction solution, and the mixture was stirred at room temperature for 1 hour. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in 500 ml of ethyl acetate, and washed with 5% weight water and water in this order. The ethyl acetate layer was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was left in the refrigerator to crystallize, hexane was added, and the product was collected by filtration to obtain the desired product [21]. Yield: 122.97 g (99.1% yield), melting point: 45
˜47 ° C. TLC; Rf 5 = 0.82 [α] 29.5 D-11.88 ° (C = 1.0, DMF)

【0055】22)PF(16−17);Boc−As
n−Ser(Bzl)−OPAC〔22〕 化合物〔21〕119.9g(0.29M)に塩化メチ
レン50mlを加え、これに氷冷下TFA250mlを加え
た後、室温で1時間攪拌した。反応後、減圧濃縮し、残
渣にエーテルを加え、析出した結晶を濾取、乾燥した。
この結晶を乾燥DMF400mlに溶かし、NMMでpH
7に中和した。この溶液にHOBt31.35g(0.
232M)およびBoc−Asn−OH53.88g
(0.232M)を加え、これに−15℃に冷却下WS
C42.46ml(0.232M)を滴下した後、室温で
一夜攪拌した。反応後、減圧下DMFを留去し、残渣を
酢酸エチル500mlに溶かし、5%重曹水で洗浄した。
分液の際、結晶が析出したので、その結晶を濾取して水
洗し、次いでエーテルで洗浄して目的物〔22〕の結晶
I41.79gを得た。濾液の酢酸エチル層は、これを
減圧濃縮し、残渣の油状物を酢酸エチル−エーテルより
結晶化して目的物〔22〕の結晶II6.22gを得
た。 収量;48.01g(収率39.2%)、融点;174
〜176℃ TLC;Rf2 =0.61、Rf4 =0.62 〔α〕29.5D−5.54°(C=1.0,DMF) アミノ酸分析;Asp1.22(1)、Ser1.00
(1)
22) PF (16-17); Boc-As
n-Ser (Bzl) -OPAC [22] 50 ml of methylene chloride was added to 119.9 g (0.29M) of compound [21], 250 ml of TFA was added thereto under ice cooling, and the mixture was stirred at room temperature for 1 hour. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the precipitated crystals were collected by filtration and dried.
Dissolve the crystals in 400 ml of dry DMF and adjust the pH with NMM.
Neutralized to 7. HOBt 31.35 g (0.
232M) and Boc-Asn-OH 53.88g.
(0.232M) was added, and the mixture was cooled to -15 ° C under WS.
After C42.46 ml (0.232M) was added dropwise, the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in 500 ml of ethyl acetate, and washed with 5% aqueous sodium hydrogen carbonate.
Crystals were precipitated during the separation, and the crystals were collected by filtration, washed with water, and then with ether to obtain 41.79 g of the target product [22] as crystals I. The ethyl acetate layer of the filtrate was concentrated under reduced pressure, and the residual oily substance was crystallized from ethyl acetate-ether to obtain 6.22 g of the target compound [22] as crystals II. Yield: 48.01 g (yield 39.2%), melting point: 174
˜176 ° C. TLC; Rf 2 = 0.61, Rf 4 = 0.62 [α] 29.5 D-5.54 ° (C = 1.0, DMF) Amino acid analysis; Asp1.22 (1), Ser1.00
(1)

【0056】23)PF(15−17);Boc−Le
u−Asn−Ser(Bzl)−OPAC〔23〕 化合物〔22〕80.91g(0.153M)に塩化メ
チレン50mlを加え、次いで氷冷下TFA150mlを加
えた後、室温で1時間攪拌した。反応液を減圧濃縮し、
残渣にエーテルを加え、生じた油状物を傾斜法により分
離した後、乾燥DMF150mlに溶かし、NMMでpH
7に中和した。この溶液にHOBt22.7g(0.1
68M)、Boc−Leu−OH・H2 O41.9g
(0.168M)およびDMF100mlを加え、−15
℃に冷却下WSC30.7ml(0.168M)を滴下し
た後、室温で攪拌した反応液がゲル化したので、氷室に
3日間静置した後、水を加え、生じた沈澱物を濾取し、
5%重曹水、水の順で洗浄、乾燥して目的物〔23〕を
得た。 収量;88.52g(収率90.3%)、融点;192
〜193℃ TLC;Rf2 =0.80、Rf3 =0.88
23) PF (15-17); Boc-Le
u-Asn-Ser (Bzl) -OPAC [23] To 80.91 g (0.153M) of compound [22], 50 ml of methylene chloride was added, and then 150 ml of TFA was added under ice cooling, followed by stirring at room temperature for 1 hour. The reaction solution is concentrated under reduced pressure,
Ether was added to the residue, and the resulting oily substance was separated by decantation, dissolved in 150 ml of dry DMF, and adjusted to pH with NMM.
Neutralized to 7. HOBt of 22.7 g (0.1
68M), Boc-Leu-OH · H 2 O41.9g
(0.168M) and DMF (100 ml) were added, and -15
30.7 ml (0.168 M) of WSC was added dropwise to the mixture while cooling to ℃, and the reaction solution stirred at room temperature gelled. After allowing it to stand in an ice room for 3 days, water was added and the resulting precipitate was collected by filtration. ,
The target product [23] was obtained by washing with 5% aqueous sodium hydrogen carbonate and water in this order and drying. Yield: 88.52 g (yield 90.3%), melting point: 192
~193 ℃ TLC; Rf 2 = 0.80 , Rf 3 = 0.88

【0057】24)PF(14−17);Boc−配列
番号:12−OPAC〔24〕 化合物〔23〕87.55g(0.137M)に塩化メ
チレン150mlを加え、次いで氷冷下TFA200mlを
加えた後、室温で70分間攪拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、生じた沈澱物を濾取、乾燥
した後、乾燥DMF200mlに溶かし、NMMでpH7
に中和して脱Boc溶液を得た。
24) PF (14-17); Boc-SEQ ID NO: 12-OPAC [24] To 87.55 g (0.137 M) of compound [23], 150 ml of methylene chloride was added, and then 200 ml of TFA under ice cooling. Then, the mixture was stirred at room temperature for 70 minutes. The reaction mixture was concentrated under reduced pressure, ether was added to the residue, the precipitate formed was collected by filtration, dried and then dissolved in 200 ml of dry DMF, and the pH was adjusted to 7 with NMM.
To neutralize to obtain a de-Boc solution.

【0058】一方、Boc−His(Tos)−OH・
DCHA89.2g(0.151M)を酢酸エチル1l
に懸濁し、1N硫酸500mlで洗浄し、析出した結晶を
濾別した。酢酸エチル層を水洗し、無水芒硝で乾燥した
後、減圧下溶媒を留去した。得られた油状物を乾燥DM
F150mlに溶解した溶液とHOBt20.4g(0.
151M)を前記の脱Boc溶液に加え、これに−15
℃に冷却下WSC27.6ml(0.151M)を滴下し
た後、室温で3日間攪拌した。反応後、減圧下溶媒を留
去し、残渣を水に加え、生じた沈澱物を濾取した後、5
%重曹水、水の順で洗浄し、乾燥して目的物〔24〕を
得た。 収量;108.63g(収率85.1%)、融点;15
4〜156℃ TLC;Rf2 =0.20、0.79、Rf3 =0.5
5、0.87 一部Tosが脱離したものが得られた。 〔α〕29.5D−18.58°(C=1.0,DMF)
On the other hand, Boc-His (Tos) -OH.
89.2 g of DCHA (0.151M) was added to 1 l of ethyl acetate.
The solid was suspended in water and washed with 1N sulfuric acid (500 ml), and the precipitated crystals were separated by filtration. The ethyl acetate layer was washed with water and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The obtained oily substance is dried DM
A solution dissolved in 150 ml of F2 and 20.4 g of HOBt (0.
151M) was added to the de-Boc solution described above and -15
27.6 ml (0.151M) of WSC was added dropwise to the mixture while cooling to 0 ° C., and the mixture was stirred at room temperature for 3 days. After the reaction, the solvent was distilled off under reduced pressure, the residue was added to water, the resulting precipitate was collected by filtration, and then 5
% Sodium bicarbonate water and water in that order, and dried to obtain the desired product [24]. Yield; 108.63 g (yield 85.1%), melting point; 15
4 to 156 ° C. TLC; Rf 2 = 0.20, 0.79, Rf 3 = 0.5
5, 0.87 A part of Tos desorbed was obtained. [Α] 29.5 D-18.58 ° (C = 1.0, DMF)

【0059】25)PF(13−17);Boc−配列
番号:13−OPAC〔25〕 化合物〔24〕107.96g(0.116M)に塩化
メチレン100mlを加え、次いで氷冷下TFA200ml
を加えた後、室温で70分間攪拌した。反応液を減圧濃
縮し、残渣にエーテルを加え、生じた沈澱物を濾取、乾
燥した後、乾燥DMF200mlに溶かし、NMMでpH
7に中和して脱Boc溶液を得た。
25) PF (13-17); Boc-SEQ ID NO: 13-OPAC [25] Compound [24] 107.96 g (0.116 M) was added with methylene chloride 100 ml, and then ice-cooled TFA 200 ml.
After adding, the mixture was stirred at room temperature for 70 minutes. The reaction mixture was concentrated under reduced pressure, ether was added to the residue, the precipitate formed was collected by filtration, dried and dissolved in 200 ml of dry DMF, and the pH was adjusted with NMM.
Neutralization to 7 gave a de-Boc solution.

【0060】一方、Boc−Lys(Z−Cl)−OH
・TBA62.46g(0.128M)を酢酸エチル6
00mlに懸濁し、1N塩酸、水の順に洗浄し、酢酸エチ
ル層を無水芒硝で乾燥後、減圧下溶媒を留去した。得ら
れた油状物とHOBt17.30g(0.128M)を
乾燥DMF100mlに溶かした溶液を前記の脱Boc溶
液に加え、これに−15℃に冷却下WSC24.42ml
(0.128M)を滴下した後、室温で一夜攪拌した。
反応後、減圧下溶媒を留去し、残渣を3%重曹水5l中
に加え、析出した結晶を充分に水洗した後、乾燥した。
この結晶をメタノールに溶かし、エーテルを加えて沈澱
化させた。得られた沈澱物を酢酸エチルに懸濁し、濾取
する工程を3回行って目的物〔25〕を得た。 収量;114.42g(収率91.8%)、融点;20
0〜202℃ TLC;Rf2 =0.34、Rf3 =0.68 〔α〕28D−26.94°(C=1.0,DMF)
On the other hand, Boc-Lys (Z-Cl) -OH
・ 62.46 g (0.128 M) of TBA was added to ethyl acetate 6
The mixture was suspended in 00 ml, washed with 1N hydrochloric acid and water in this order, the ethyl acetate layer was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. A solution prepared by dissolving 17.30 g (0.128 M) of the obtained oil and HOBt in 100 ml of dry DMF was added to the de-Boc solution described above, and 24.42 ml of WSC under cooling to -15 ° C.
(0.128M) was added dropwise, and the mixture was stirred at room temperature overnight.
After the reaction, the solvent was distilled off under reduced pressure, the residue was added to 5 l of 3% sodium hydrogen carbonate solution, and the precipitated crystals were thoroughly washed with water and dried.
The crystals were dissolved in methanol, and ether was added for precipitation. The obtained precipitate was suspended in ethyl acetate and collected by filtration three times to obtain the desired product [25]. Yield: 114.42 g (91.8% yield), melting point: 20
0 to 202 ° C. TLC; Rf 2 = 0.34, Rf 3 = 0.68 [α] 28 D-26.94 ° (C = 1.0, DMF)

【0061】26)PF(13−17);Boc−配列
番号:13−OH〔25〕 化合物〔25〕86.0g(80mM)を酢酸500ml
に溶かし、これに亜鉛末150gを加え、室温で5時間
攪拌した後、反応液を濾過して亜鉛末を除去した。反応
濾液を減圧濃縮し、残渣にエーテルを加え、析出した結
晶を濾取して目的物〔26〕を得た。 収量;84.70g(収率95.2%)、融点;240
〜250℃ TLC;Rf2 =0.47 〔α〕30D−19.16°(C=1.0,DMF) 元素分析〔C4552129 Cl・2CH3 COOH・
2H2 Oとして〕 アミノ酸分析;Asp1.01(1)、Ser0.83
(1)、Leu1(1)、Lys0.93(1)、Hi
s0.97(1)
26) PF (13-17); Boc-SEQ ID NO: 13-OH [25] Compound [25] 86.0 g (80 mM) was added to 500 ml of acetic acid.
150 g of zinc dust was added thereto, the mixture was stirred at room temperature for 5 hours, and the reaction liquid was filtered to remove zinc dust. The reaction filtrate was concentrated under reduced pressure, ether was added to the residue, and the precipitated crystals were collected by filtration to obtain the desired product [26]. Yield: 84.70 g (95.2% yield), melting point: 240
˜250 ° C. TLC; Rf 2 = 0.47 [α] 30 D-19.16 ° (C = 1.0, DMF) Elemental analysis [C 45 H 52 O 12 N 9 Cl.2CH 3 COOH.
2H 2 O] Amino acid analysis; Asp1.01 (1), Ser0.83
(1), Leu1 (1), Lys0.93 (1), Hi
s0.97 (1)

【0062】27)PF(13−34);Boc−配列
番号:14−NH2〔27〕 化合物〔20〕10.77g(3.2mM)にスカトー
ル0.46g(3.2mM)、ジメチルスルフイド25
ml、エタンジチオール2.5mlおよびTFA25mlを加
え、0℃で10分間、室温で60分間攪拌した後、反応
液を減圧濃縮した。残渣にエーテルを加え、生じた沈澱
物を濾取、乾燥した後、乾燥DMF200mlに溶かし、
NMMでpH7に中和した。次いで、これにHOBt
0.51g(3.8mM)および化合物〔26〕4.2
3g(3.8mM)を加え、−15℃に冷却下WSC
0.70mlを加えた後、室温で一夜攪拌した。反応後、
減圧下DMFを留去し、残渣に水を加え、生じた沈澱物
を濾取し、水洗、乾燥して目的物〔27〕を得た。 収量;13.60g(収率100%)、融点;138〜
160.5℃ 〔α〕28D−1.96°(C=0.56,DMF) アミノ酸分析;Asp2.96(3)、Ser0.62
(1)、Glu3.02(3)、Val1.72
(2)、Leu3(3)、Tyr1.06(1)、Ly
s3.01(3)、His1.43(2)、Arg1.
98(2)、Trp0.60(1)、NIe1.06
(1)
27) PF (13-34); Boc-SEQ ID NO: 14-NH 2 [27] Compound [20] 10.77 g (3.2 mM) and 0.46 g (3.2 mM) skatole and dimethyl sulfone. Id 25
ml, ethanedithiol 2.5 ml and TFA 25 ml were added, and the mixture was stirred at 0 ° C. for 10 minutes and at room temperature for 60 minutes, and then the reaction solution was concentrated under reduced pressure. Ether was added to the residue, the resulting precipitate was collected by filtration, dried and then dissolved in 200 ml of dry DMF.
Neutralized to pH 7 with NMM. Then add HOBt
0.51 g (3.8 mM) and compound [26] 4.2
Add 3 g (3.8 mM) and cool to -15 ° C under WSC
After adding 0.70 ml, the mixture was stirred overnight at room temperature. After the reaction
DMF was distilled off under reduced pressure, water was added to the residue, and the resulting precipitate was collected by filtration, washed with water and dried to obtain the desired product [27]. Yield: 13.60 g (yield 100%), melting point: 138-
160.5 ° C. [α] 28 D-1.96 ° (C = 0.56, DMF) Amino acid analysis; Asp2.96 (3), Ser0.62
(1), Glu3.02 (3), Val1.72
(2), Leu3 (3), Tyr1.06 (1), Ly
s3.01 (3), His1.43 (2), Arg1.
98 (2), Trp0.60 (1), NIe1.06
(1)

【0063】28)PF(11−12);Boc−Le
u−Gly−OBzl〔28〕 Boc−Leu−OH・H2 O4.99g(20mM)
を乾燥THF30mlに溶かし、これに乾燥ベンゼン50
mlを加え、溶媒を共沸により留去した。得られた油状物
を乾燥THF70mlに溶かし、これにH−Gly−OB
zl・TosOH(20mM)およびHOBt2.7g
(20mM)を加え、次いで−15℃に冷却下WSC5
mlを加えた後、室温で一夜攪拌した。反応後、減圧下溶
媒を留去し、残渣を酢酸エチル100mlに溶かした後、
1N塩酸で2回、5%重曹水で2回、水で2回の順で洗
浄した。酢酸エチル層を無水芒硝で乾燥した後、減圧濃
縮して油状の目的物〔28〕を得た。
28) PF (11-12); Boc-Le
u-Gly-OBzl [28] Boc-Leu-OH.H 2 O 4.99 g (20 mM)
Was dissolved in 30 ml of dry THF, and 50 ml of dry benzene was added to this.
ml was added and the solvent was distilled off azeotropically. The oily substance obtained was dissolved in 70 ml of dry THF, and added with H-Gly-OB.
zl TosOH (20 mM) and HOBt 2.7 g
(20 mM) and then WSC5 under cooling to -15 ° C.
After adding ml, the mixture was stirred overnight at room temperature. After the reaction, the solvent was distilled off under reduced pressure and the residue was dissolved in 100 ml of ethyl acetate.
It was washed twice with 1N hydrochloric acid, twice with 5% aqueous sodium hydrogen carbonate and twice with water. The ethyl acetate layer was dried over anhydrous sodium sulfate and then concentrated under reduced pressure to obtain an oily target product [28].

【0064】29)PF(10−12);Boc−As
n−Leu−Gly−OBzl〔29〕 前記で得た油状物〔28〕に−15℃に冷却下4.39
N塩化水素/ジオキサン溶液40mlを加え、90分間攪
拌した後、減圧濃縮した。残渣にエーテルを加え、生じ
た沈澱物を濾取、乾燥した後、乾燥DMF30mlに溶か
した。これに−5℃に冷却下Et3 Nを加えてpH7に
調節し、次いでHOBt0.3g(2.2mM)および
Boc−Asn−ONP7.77g(2.2mM)およ
びBoc−Asn−ONP7.77g(22mM)を加
え、室温で3日間攪拌した。反応に水を加え、析出した
沈澱物をクロロホルム200mlで抽出した。クロロホル
ム層を1N塩酸、5%重曹水、水の順で洗浄し、無水芒
硝で乾燥後、減圧下溶媒を留去した。残渣を酢酸エチル
−ヘキサンから結晶化して目的物〔29〕を得た。 収量;8.0g(収率73.8%)、融点;152〜1
56℃ 〔α〕24D−36.1°(C=1.0,DMF)
29) PF (10-12); Boc-As
n-Leu-Gly-OBzl [29] The oily substance [28] obtained above was cooled to -15 ° C under 4.39.
After adding 40 ml of N hydrogen chloride / dioxane solution and stirring for 90 minutes, the solution was concentrated under reduced pressure. Ether was added to the residue, the resulting precipitate was collected by filtration, dried and then dissolved in 30 ml of dry DMF. Added under cooling Et 3 N to the -5 ° C. and adjusted to pH 7, then HOBt0.3g (2.2mM) and Boc-Asn-ONP7.77g (2.2mM) and Boc-Asn-ONP7.77g ( (22 mM) was added, and the mixture was stirred at room temperature for 3 days. Water was added to the reaction, and the deposited precipitate was extracted with 200 ml of chloroform. The chloroform layer was washed with 1N hydrochloric acid, 5% aqueous sodium hydrogen carbonate and water in that order, dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was crystallized from ethyl acetate-hexane to obtain the desired product [29]. Yield: 8.0 g (yield 73.8%), melting point: 152-1
56 ° C [α] 24 D-36.1 ° (C = 1.0, DMF)

【0065】30)PF(9−12);Boc−配列番
号:15−OBzl〔30〕 化合物〔29〕7.36g(15.5mM〕に塩化メチ
レン5mlを加え、次いで氷冷下にTFA32mlを加えた
後、室温で60分間攪拌した。反応液を減圧濃縮し、残
渣にエーテルを加え、析出した沈澱物を濾取、乾燥した
後、乾燥DMF40mlに溶かし、NMMでpH7に調節
して脱Boc溶液を得た。
30) PF (9-12); Boc-SEQ ID NO: 15-OBzl [30] Compound [29] 7.36 g (15.5 mM) was added with methylene chloride 5 ml and then ice-cooled with TFA 32 ml. After stirring for 60 minutes at room temperature, the reaction mixture was concentrated under reduced pressure, ether was added to the residue, and the deposited precipitate was collected by filtration, dried, dissolved in 40 ml of dry DMF, and adjusted to pH 7 with NMM to remove the Boc solution. Got

【0066】一方、Boc−His(Tos)−OH・
DCHA10.99g(18.6mM)に酢酸エチル1
50mlおよび0.5N硫酸90mlを加えて振とうし、酢
酸エチル層を水で3回洗浄し、無水芒硝で乾燥後、酢酸
エチルを減圧下留去して油状物を得た。この油状物とH
OBt2.5g(18.6mM)を乾燥DMF60mlに
溶かし、その溶液を前記の脱Boc溶液に加え、次いで
−15℃に冷却下WSC3.4ml(18.6mM)を加
えた後、室温で一夜攪拌した。反応後、減圧下溶媒を留
去し、残渣を酢酸エチルに溶かし、5%重曹水で3回、
水で2回洗浄し、無水芒硝で乾燥後、減圧下溶媒を留去
した。残渣にエーテルを加え、析出した結晶を濾取し
た。この結晶はHisのTosが一部脱離されている
が、完全に脱離するために、この結晶をDMF100ml
に溶解し、これにHOBt7.05gを加え、室温で3
日間攪拌した。反応後、減圧下DMFを留去し、残渣を
酢酸エチルに溶かし、5%重曹水で2回、水の順に洗浄
し、無水芒硝で乾燥後、減圧下溶媒を留去した。析出し
た結晶にエーテルを加えて濾取して目的物〔30〕を得
た。 収量;7.32g(収率74.8%)、TLC;Rf2
=0.1
On the other hand, Boc-His (Tos) -OH.
DCHA 10.99 g (18.6 mM) and ethyl acetate 1
50 ml and 90 ml of 0.5N sulfuric acid were added, and the mixture was shaken. The ethyl acetate layer was washed 3 times with water and dried over anhydrous sodium sulfate, and ethyl acetate was evaporated under reduced pressure to give an oily substance. This oil and H
2.5 g of OBt (18.6 mM) was dissolved in 60 ml of dry DMF, the solution was added to the de-Boc solution described above, and then 3.4 ml of WSC (18.6 mM) was added under cooling to -15 ° C, followed by stirring at room temperature overnight. . After the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in ethyl acetate, and the mixture was washed with 5% aqueous sodium hydrogen carbonate three times,
After washing twice with water and drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected by filtration. Toss of His is partially desorbed in this crystal, but in order to completely desorb it, 100 ml of DMF was added to this crystal.
And HOBt 7.05 g was added to this, and the mixture was stirred at room temperature for 3 hours.
It was stirred for a day. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in ethyl acetate, washed twice with 5% aqueous sodium hydrogen carbonate and in this order with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. Ether was added to the precipitated crystals and the crystals were collected by filtration to obtain the desired product [30]. Yield: 7.32 g (74.8% yield), TLC: Rf 2
= 0.1

【0067】31)PF(8−12);Boc−配列番
号:16−OBzl〔31〕 化合物〔30〕7.32g(11.6mM〕に塩化メチ
レン5mlを加え、次いで氷冷下TFA30mlを加えた
後、室温で40分間攪拌した。反応液を減圧濃縮し、残
渣にエーテルを加え、析出した沈澱物を濾取、乾燥した
後、乾燥DMF40mlに溶かし、NMMでpH7に調節
した。これにHOBt1.9g(13.92mM)およ
びBoc−Nle−OH3.23g(13.92mM)
を乾燥DMFに溶かした溶液を加え、−15℃に冷却下
WSC2.5ml(13.92mM)を加えた後、室温で
一夜攪拌した。反応後、減圧下溶媒を留去し、残渣に水
を加え、析出した沈澱物を濾取し、5%重曹水で2回、
1N塩酸で2回、水で3回の順で洗浄し、乾燥して目的
物〔31〕を得た。 収量;3.70g(収率42.9%)、TLC;Rf2
=0.20
31) PF (8-12); Boc-SEQ ID NO: 16-OBzl [31] To 7.32 g (11.6 mM) of compound [30], 5 ml of methylene chloride was added, and then 30 ml of TFA under ice cooling. After that, the reaction mixture was concentrated under reduced pressure, ether was added to the residue, the deposited precipitate was collected by filtration, dried, dissolved in 40 ml of dry DMF, and adjusted to pH 7 with NMM. 9 g (13.92 mM) and Boc-Nle-OH 3.23 g (13.92 mM)
Was added to dry DMF, 2.5 ml (13.92 mM) of WSC was added under cooling to -15 ° C, and the mixture was stirred at room temperature overnight. After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, and the deposited precipitate was collected by filtration and washed twice with 5% aqueous sodium hydrogen carbonate,
The product was washed twice with 1N hydrochloric acid and then three times with water, and dried to obtain the desired product [31]. Yield: 3.70 g (yield 42.9%), TLC; Rf 2
= 0.20

【0068】32)PF(8−12);Boc−配列番
号:16−OH〔32〕 化合物〔31〕2.8g(3.8mM〕をエタノール1
00mlに溶かし、これに10%Pd/C300mgを加
え、室温で水素ガスを3時間通じた。反応液中に不純物
が析出したので、濾過し、DMFで洗浄した後、濾液を
減圧濃縮した。残渣にエタノール−エーテルを加えて沈
澱物を濾取、乾燥して目的物〔32〕を得た。 収量;1.76g(収率71.1%)、融点;112.
5℃ TLC;Rf2 =0.05 アミノ酸分析;Asp0.96(1)、Gly0.98
(1)、Leu1(1)、His0.95(1)、Nl
e0.94(1)
32) PF (8-12); Boc-SEQ ID NO: 16-OH [32] Compound [31] 2.8 g (3.8 mM) was added to ethanol 1
It was dissolved in 00 ml, 10% Pd / C (300 mg) was added thereto, and hydrogen gas was bubbled through at room temperature for 3 hours. Impurities were precipitated in the reaction solution, so they were filtered, washed with DMF, and the filtrate was concentrated under reduced pressure. Ethanol-ether was added to the residue and the precipitate was collected by filtration and dried to obtain the desired product [32]. Yield: 1.76 g (71.1% yield), melting point: 112.
5 ° C. TLC; Rf 2 = 0.05 amino acid analysis; Asp 0.96 (1), Gly 0.98
(1), Leu1 (1), His0.95 (1), Nl
e 0.94 (1)

【0069】33)PF(8−34);Boc−配列番
号:17−NH2 〔33〕 化合物〔27〕10.60g(2.5mM〕にスカトー
ル0.33g(2.5mM)、ジメチルスルフイド25
ml、エタンジチオール2.5mlおよびTFA25mlを加
え、0℃で10分、室温で50分間それぞれ攪拌した
後、反応液を減圧濃縮した。残渣にエーテルを加え、生
じた沈澱物を濾取、乾燥した後、乾燥DMF100mlに
溶かし、これに氷冷下NMMを加えてpH7に調節し
た。この溶液にHOBt0.36g(2.7mM)およ
び化合物〔32〕1.76g(2.7mM)を加え、−
15℃に冷却下WSC0.5mlを加えた後、室温で一夜
攪拌した。析出した沈澱物を濾取し、水で洗浄、乾燥し
た後、エタノール−エーテルから再沈澱して目的物〔3
3〕を得た。 収量;10.94g(収率91.7%)、融点;14
0.5〜162℃ 〔α〕28D−1.94°(C=0.52,DMF) アミノ酸分析;Asp3.87(4)、Ser0.76
(1)、Glu3.34(3)、Gly0.77
(1)、Val1.84(2)、Leu4(4)、Ty
r1.04(1)、Lys3.28(3)、His2.
37(3)、Arg2.14(2)、Trp0.73
(1)、Nle2.07(2)
33) PF (8-34); Boc-SEQ ID NO: 17-NH 2 [33] Compound [27] 10.60 g (2.5 mM) to skatole 0.33 g (2.5 mM), dimethylsulf Id 25
ml, ethanedithiol 2.5 ml and TFA 25 ml were added, and the mixture was stirred at 0 ° C. for 10 minutes and at room temperature for 50 minutes, and then the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected by filtration, dried, dissolved in 100 ml of dry DMF, and NMM was added thereto under ice cooling to adjust the pH to 7. To this solution was added HOBt 0.36 g (2.7 mM) and compound [32] 1.76 g (2.7 mM), and-
After adding 0.5 ml of WSC to 15 ° C. under cooling, the mixture was stirred overnight at room temperature. The deposited precipitate was collected by filtration, washed with water and dried, and then reprecipitated from ethanol-ether to obtain the desired product [3
3] was obtained. Yield: 10.94 g (91.7% yield), melting point: 14
0.5 to 162 ° C. [α] 28 D-1.94 ° (C = 0.52, DMF) Amino acid analysis; Asp3.87 (4), Ser0.76
(1), Glu3.34 (3), Gly0.77
(1), Val1.84 (2), Leu4 (4), Ty
r1.04 (1), Lys3.28 (3), His2.
37 (3), Arg2.14 (2), Trp0.73
(1), Nle2.07 (2)

【0070】34)PF(7);Boc−Leu−OP
AC〔34〕 Boc−Leu−OH・H2 O15.0g(60mM)
とフエナシルブロマイド17.9g(90mM)をDM
F100mlに溶かし、これに氷冷下Et3 N12.5ml
(90mM)を滴下した後、30℃で2時間攪拌した。
次いで酢酸カリウム4.42g(45mM)を加え、室
温で45分間攪拌した後、減圧下DMFを留去した。残
渣を酢酸エチルに溶かし、5%重曹水で2回、水で2回
洗浄し、酢酸エチル層を無水芒硝で乾燥後、減圧下溶媒
を留去した。残渣を氷室に放置し、析出した結晶を乾燥
して目的物〔34〕を得た。 収量;21.23g(収率100%)、TLC;Rf1
=0.89
34) PF (7); Boc-Leu-OP
AC [34] Boc-Leu-OH · H 2 O15.0g (60mM)
DM with 17.9 g (90 mM) of phenacyl bromide
Dissolve in 100 ml of F and add 12.5 ml of Et 3 N under ice cooling.
(90 mM) was added dropwise, and the mixture was stirred at 30 ° C for 2 hours.
Next, 4.42 g (45 mM) of potassium acetate was added, the mixture was stirred at room temperature for 45 minutes, and then DMF was distilled off under reduced pressure. The residue was dissolved in ethyl acetate and washed twice with 5% aqueous sodium hydrogen carbonate and twice with water. The ethyl acetate layer was dried over anhydrous sodium sulfate and the solvent was evaporated under reduced pressure. The residue was left in an ice room, and the precipitated crystals were dried to obtain the desired product [34]. Yield; 21.23 g (yield 100%), TLC; Rf 1
= 0.89

【0071】35)PF(6−7);Boc−Glu−
Leu−OPAC〔35〕 化合物〔34〕20.96g(60mM)に塩化メチレ
ン20mlを加え、次いで氷冷下TFA80mlを加え、室
温で40分間攪拌した後、反応液を減圧濃縮した。残渣
にエーテルを加え、生じた沈澱物を濾取、乾燥した後、
乾燥DMF70mlに溶かし、氷冷下NMMを加えてpH
7に調節した。この溶液にHOBt8.1g(60m
M)およびBoc−Gln−OH14.78g(60m
M)を乾燥DMF90mlに溶かした溶液を加え、−15
℃に冷却下WSC10.9ml(60mM)を滴下した
後、室温で一夜攪拌した。反応後、DMFを減圧留去
し、残渣を酢酸エチルに溶かした後、5%重曹水で2
回、1N塩酸で2回、水で3回の順で洗浄した。酢酸エ
チル層を無水芒硝で乾燥後、減圧下溶媒を留去した後、
析出した結晶にヘキサンを加えて濾取、乾燥して目的物
〔35〕を得た。 収量;17.25g(収率60.2%)、TLC;Rf
1 =0.38
35) PF (6-7); Boc-Glu-
Leu-OPAC [35] 20 ml of methylene chloride was added to 20.96 g (60 mM) of compound [34], 80 ml of TFA was added thereto under ice cooling, and the mixture was stirred at room temperature for 40 minutes, and the reaction mixture was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected by filtration and dried,
Dissolve in 70 ml of dry DMF, add NMM under ice cooling and add pH.
Adjusted to 7. HOBt 8.1g (60m
M) and Boc-Gln-OH 14.78 g (60 m)
A solution of M) in 90 ml of dry DMF was added, and -15
WSC (10.9 ml, 60 mM) was added dropwise to the mixture while cooling to 0 ° C., and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, the residue was dissolved in ethyl acetate, and the mixture was washed with 5% aqueous sodium hydrogencarbonate solution 2
It was washed twice with 1N hydrochloric acid, and then with water 3 times. After drying the ethyl acetate layer with anhydrous sodium sulfate, after distilling off the solvent under reduced pressure,
Hexane was added to the precipitated crystals, and the crystals were collected by filtration and dried to obtain the target product [35]. Yield; 17.25 g (60.2% yield), TLC; Rf
1 = 0.38

【0072】36)PF(5−7);Boc−Ile−
Gln−Leu−OPAC〔36〕 化合物〔35〕17.19g(36mM)に塩化メチレ
ン10mlを加え、次いで氷冷下TFA70mlを加え、室
温で60分間攪拌した後、反応液を減圧濃縮した。残渣
を減圧乾燥後、乾燥DMF130mlに溶かし、氷冷下N
MMでpH7に調節した。この溶液にHOBt5.3g
(39.6mM)およびBoc−Ile−OH・1/2
2 O9.5g(39.6mM)を乾燥DMF70mlに
溶かした溶液を加え、−15℃に冷却下WSC7.2ml
(39.6mM)を滴下した後、室温で一夜攪拌した。
反応後、DMFを減圧留去し、残渣に5%重曹水を加
え、生じた沈澱物を濾取した後、5%重曹水、1N塩酸
で2回、水で3回の順で洗浄し、乾燥した。この沈澱物
をエタノール−エーテルから再沈澱して目的物〔36〕
を得た。 収量;16.35g(収率76.9%) TLC;Rf1 =0.41、Rf2 =0.68
36) PF (5-7); Boc-Ile-
Gln-Leu-OPAC [36] To 17.19 g (36 mM) of compound [35], 10 ml of methylene chloride was added, and then 70 ml of TFA was added under ice cooling, and the mixture was stirred at room temperature for 60 minutes, and the reaction mixture was concentrated under reduced pressure. The residue was dried under reduced pressure, dissolved in 130 ml of dry DMF, and cooled under ice cooling N
The pH was adjusted to 7 with MM. HOBt 5.3g in this solution
(39.6 mM) and Boc-Ile-OH.1 / 2
A solution prepared by dissolving 9.5 g of H 2 O (39.6 mM) in 70 ml of dry DMF was added, and WSC (7.2 ml) was cooled to -15 ° C.
After (39.6 mM) was added dropwise, the mixture was stirred overnight at room temperature.
After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium hydrogen carbonate was added to the residue, and the resulting precipitate was collected by filtration and washed with 5% aqueous sodium hydrogen carbonate twice, 1N hydrochloric acid twice and water three times in this order. Dried. This precipitate was reprecipitated from ethanol-ether to give the desired product [36].
Got Yield: 16.35 g (yield: 76.9%) TLC; Rf 1 = 0.41, Rf 2 = 0.68

【0073】37)PF(4−7);Boc−配列番
号:18−OPAC〔37〕 化合物〔37〕16.24g(27.5mM)に塩化メ
チレン10mlを加え、次いで氷冷下TFA70mlを加
え、室温で60分間攪拌した後、反応液を減圧濃縮し
た。残渣にエーテルを加え、生じた沈澱物を濾取、乾燥
した後、乾燥DMF100mlに溶かし、次いで氷冷下N
MMを加えてpH7に調節した。この溶液にHOBt
4.09g(30.25mM)およびBoc−Glu
(OBzl)−OH10.2g(30.25mM)を乾
燥DMF50mlに溶かした溶液を加え、−15℃に冷却
下WSC5.5mlを滴下した後、室温で一夜攪拌した。
反応後、DMFを減圧留去し、残渣に5%重曹水を加
え、生じた沈澱物を濾取した後、5%重曹水、1N塩酸
で2回、水で4回の順で洗浄し、乾燥した。エタノール
−エーテルから再沈澱して目的物〔37〕を得た。 収量;21.68g(収率97.1%) TLC;Rf1 =0.52
37) PF (4-7); Boc-SEQ ID NO: 18-OPAC [37] To 16.24 g (27.5 mM) of compound [37], 10 ml of methylene chloride was added, and then 70 ml of TFA was added under ice cooling. After stirring at room temperature for 60 minutes, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected by filtration, dried, dissolved in 100 ml of dry DMF, and then N-cooled under ice cooling.
The pH was adjusted to 7 by adding MM. HOBt in this solution
4.09 g (30.25 mM) and Boc-Glu
A solution of 10.2 g (30.25 mM) of (OBzl) -OH dissolved in 50 ml of dry DMF was added, and 5.5 ml of WSC was added dropwise to the mixture at -15 ° C under cooling, followed by stirring at room temperature overnight.
After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium hydrogen carbonate was added to the residue, and the resulting precipitate was collected by filtration and washed with 5% aqueous sodium hydrogen carbonate twice, 1N hydrochloric acid twice and water four times in this order. Dried. Reprecipitation from ethanol-ether gave the desired product [37]. Yield: 21.68 g (yield 97.1%) TLC; Rf 1 = 0.52

【0074】38)PF(3−7);Boc−配列番
号:19−OPAC〔38〕 化合物〔37〕21.46g(26.5mM)に塩化メ
チレン10mlを加え、次いで氷冷下TFA90mlを加
え、室温で1時間攪拌した後、反応液を減圧濃縮した。
残渣にエーテルを加え、生じた沈澱物を濾取、乾燥した
後、乾燥DMF150mlに溶かし、次いで氷冷下NMM
を加えてpH7に調節した。この溶液にHOBt3.9
g(29.15mM)およびBoc−Ser(Bzl)
−OH8.6g(29.15mM)を乾燥DMF50ml
に溶かした溶液を加え、−15℃に冷却下WSC5.3
ml(29.15mM)を加えた後、室温で一夜攪拌し
た。反応後、DMFを減圧留去し、残渣に5%重曹水を
加え、析出した沈澱物を濾取した。これを5%重曹水、
1N塩酸で2回、水で4回の順で洗浄した後、エーテル
に懸濁、濾取して目的物〔38〕を得た。 収量;24.8g(収率94.7%)、TLC;Rf1
=0.53
38) PF (3-7); Boc-SEQ ID NO: 19-OPAC [38] To 21.46 g (26.5 mM) of compound [37], 10 ml of methylene chloride was added, and then 90 ml of TFA was added under ice cooling. After stirring at room temperature for 1 hour, the reaction solution was concentrated under reduced pressure.
Ether was added to the residue, and the resulting precipitate was collected by filtration, dried, dissolved in 150 ml of dry DMF, and then NMM under ice cooling.
Was added to adjust the pH to 7. HOBt 3.9 was added to this solution.
g (29.15 mM) and Boc-Ser (Bzl)
-OH 8.6g (29.15mM) dry DMF 50ml
Was added to the solution and cooled to −15 ° C. under WSC5.3.
After adding ml (29.15 mM), the mixture was stirred overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium hydrogen carbonate was added to the residue, and the deposited precipitate was collected by filtration. 5% sodium bicarbonate water,
After washing with 1N hydrochloric acid twice and water four times in this order, the product was suspended in ether and collected by filtration to obtain the desired product [38]. Yield: 24.8 g (yield 94.7%), TLC; Rf 1
= 0.53

【0075】39)PF(2−7);Boc−配列番
号:20−OPAC〔39〕 化合物〔38〕24.68g(25mM)に塩化メチレ
ン20mlを加え、次いで氷冷下TFA100mlを加えた
後、室温で50分間攪拌した後、反応液を減圧濃縮し、
残渣にエーテルを加え、生じた沈澱物を濾取、乾燥した
後、乾燥DMF120mlに溶かし、次いで氷冷下NMM
を加えてpH7に調節した。この溶液にHOBt4.0
5g(30mM)およびBoc−Val−OH6.5g
(30mM)を乾燥DMF80mlに溶かした溶液を加
え、−15℃に冷却下WSC5.5ml(30mM)を滴
下した後、室温で一夜攪拌した。反応液に沈澱物が析出
したので、水を加えて濾取し、5%重曹水で2回、1N
塩酸で2回、水で4回の順で洗浄した後、エーテルに懸
濁、濾取して目的物〔39〕を得た。 収量;26.32g(収率96.8%)、TLC;Rf
1 =0.49
39) PF (2-7); Boc-SEQ ID NO: 20-OPAC [39] To 24.68 g (25 mM) of compound [38], 20 ml of methylene chloride was added, and then 100 ml of TFA was added under ice cooling. After stirring at room temperature for 50 minutes, the reaction solution was concentrated under reduced pressure,
Ether was added to the residue, and the resulting precipitate was collected by filtration, dried and dissolved in 120 ml of dry DMF, and then NMM under ice cooling.
Was added to adjust the pH to 7. Add HOBt 4.0 to this solution.
5 g (30 mM) and Boc-Val-OH 6.5 g
A solution prepared by dissolving (30 mM) in 80 ml of dry DMF was added, and 5.5 ml (30 mM) of WSC was added dropwise to the mixture at -15 ° C under cooling, followed by stirring at room temperature overnight. Since a precipitate had precipitated in the reaction solution, water was added to it, and the precipitate was collected by filtration and washed twice with 5% aqueous sodium hydrogen carbonate and 1N.
After washing twice with hydrochloric acid and then four times with water, the product was suspended in ether and collected by filtration to obtain the desired product [39]. Yield: 26.32 g (yield 96.8%), TLC; Rf
1 = 0.49

【0076】40)PF(1−7);Boc−配列番
号:21−OPAC〔40〕 化合物〔39〕26.07g(24mM)に塩化メチレ
ン20mlを加え、次いで氷冷下TFA100mlを加えた
後、室温で40分間攪拌した後、反応液を減圧濃縮し、
残渣にエーテルを加え、生じた沈澱物を濾取、乾燥した
後、乾燥DMF100mlに溶かし、次いで氷冷下NMM
を加えてpH7に調節した。この溶液にHOBt3.9
g(28.8mM)およびBoc−Ser(Bzl)−
OH8.5g(28.8mM)を乾燥DMF50mlに溶
かした溶液を加え、−15℃に冷却下WSC5.3ml
(28.8mM)を添加した後、室温で一夜攪拌した。
反応液に沈澱物が析出したので、水を加えて濾取し、5
%重曹水、1N塩酸、水の順で洗浄した後、エーテルに
懸濁、濾取する工程を2回行って目的物〔40〕を得
た。 収量;28.0g(収率92.3%)、TLC;Rf1
=0.53
40) PF (1-7); Boc-SEQ ID NO: 21-OPAC [40] To 26.07 g (24 mM) of compound [39], 20 ml of methylene chloride was added, and then 100 ml of TFA was added under ice cooling. After stirring at room temperature for 40 minutes, the reaction solution was concentrated under reduced pressure,
Ether was added to the residue, and the resulting precipitate was collected by filtration, dried, dissolved in 100 ml of dry DMF, and then NMM under ice cooling.
Was added to adjust the pH to 7. HOBt 3.9 was added to this solution.
g (28.8 mM) and Boc-Ser (Bzl)-
A solution prepared by dissolving 8.5 g (28.8 mM) of OH in 50 ml of dry DMF was added, and 5.3 ml of WSC under cooling to -15 ° C.
After adding (28.8 mM), the mixture was stirred at room temperature overnight.
Since a precipitate had precipitated in the reaction solution, water was added and the mixture was collected by filtration.
% Sodium bicarbonate water, 1N hydrochloric acid, and water in this order, and then the steps of suspending in ether and collecting by filtration were performed twice to obtain the target product [40]. Yield: 28.0 g (yield 92.3%), TLC; Rf 1
= 0.53

【0077】41)PF(1−7);Boc−配列番
号:21−OH〔41〕 化合物〔40〕12.6g(10mM)を酢酸300ml
に溶かし、これに亜鉛末15gを加え、50℃で4時間
攪拌した後、亜鉛末を濾別した。酢酸を減圧留去し、残
渣にエーテルを加え、析出した結晶を濾取、洗浄して目
的物〔41〕を得た。 収量;11.15g(収率97.4%)、融点;260
℃(分解) TLC;Rf1 =0.14、Rf2 =0.64 アミノ酸分析;Ser1.81(2)、Glu2.02
(2)、Val0.95(1)、Leu1(1)、Il
e0.92(1)
41) PF (1-7); Boc-SEQ ID NO: 21-OH [41] Compound [40] 12.6 g (10 mM) was added to acetic acid 300 ml.
15 g of zinc dust was added thereto, the mixture was stirred at 50 ° C. for 4 hours, and the zinc dust was filtered off. Acetic acid was distilled off under reduced pressure, ether was added to the residue, and the precipitated crystals were collected by filtration and washed to obtain the desired product [41]. Yield: 11.15 g (97.4% yield), melting point: 260
C (decomposition) TLC; Rf 1 = 0.14, Rf 2 = 0.64 amino acid analysis; Ser1.81 (2), Glu2.02
(2), Val0.95 (1), Leu1 (1), Il
e 0.92 (1)

【0078】42)保護−〔Nle8 ,Nle18,Tr
34〕−h−PTH(1−34)NH2 ;Boc−配列
番号:22−NH2 〔42〕 化合物〔33〕10.86g(2.28mM)に氷冷下
スカトール0.30g(2.28mM)、ジメチルスル
フイド25ml、エタンジチオール2.5mlおよびTFA
25mlを加え、室温で60分間攪拌した後、減圧濃縮し
た。残渣にエーテルを加え、生じた沈澱物を濾取、乾燥
した後、乾燥DMF100ml+DMSO10mlの混液に
溶かし、次いで氷冷下NMMを加えてpH7に調節し
た。この溶液にHOBt0.37g(2.74mM)お
よび化合物〔41〕3.14g(2.74mM)を加
え、次いで−15℃に冷却下WSC0.50ml(2.7
4mM)を加えた後、室温で一夜攪拌した。反応液に水
を加え、生じた沈澱物を濾取し、充分に水洗した後、エ
タノール−エーテルで洗浄して目的物〔42〕を得た。 収量;12.87g(収率97.3%)、融点;13
9.5〜175℃ 〔α〕28D−1.97°(C=0.51,DMF) アミノ酸分析;Asp3.72(4)、Ser2.76
(3)、Glu5.58(5)、Gly0.69
(1)、Val2.86(3)、Ile1.11
(1)、Leu5(5)、Tyr0.99(1)、Ly
s2.87(3)、His2.19(3)、Arg2.
06(2)、Trp0.65(1)、Nle1.96
(2)
42) Protection- [Nle 8 , Nle 18 , Tr
y 34 ] -h-PTH (1-34) NH 2 ; Boc-SEQ ID NO: 22-NH 2 [42] Compound [33] 10.86 g (2.28 mM) in ice-cooled skatole 0.30 g (2. 28 mM), dimethyl sulfide 25 ml, ethanedithiol 2.5 ml and TFA
After adding 25 ml and stirring at room temperature for 60 minutes, the mixture was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected by filtration, dried and dissolved in a mixed solution of 100 ml of dry DMF + 10 ml of DMSO, and then NMM was added under ice cooling to adjust the pH to 7. To this solution, 0.37 g (2.74 mM) of HOBt and 3.14 g (2.74 mM) of compound [41] were added, and then 0.50 ml (2.7%) of WSC under cooling to -15 ° C.
(4 mM) was added, and the mixture was stirred overnight at room temperature. Water was added to the reaction solution, the resulting precipitate was collected by filtration, washed thoroughly with water, and then washed with ethanol-ether to obtain the desired product [42]. Yield: 12.87 g (yield 97.3%), melting point: 13
9.5 to 175 ° C. [α] 28 D-1.97 ° (C = 0.51, DMF) Amino acid analysis; Asp 3.72 (4), Ser 2.76
(3), Glu5.58 (5), Gly0.69
(1), Val2.86 (3), Ile1.11
(1), Leu5 (5), Tyr0.99 (1), Ly
s2.87 (3), His2.19 (3), Arg2.
06 (2), Trp0.65 (1), Nle1.96
(2)

【0079】43)〔Nle8 ,Nle18,Try34
−h−PTH(1−34)NH2 化合物〔42〕2.9g(0.5mM)に0℃に冷却下
アニソール3.5ml、エタンジチオール0.35ml、ジ
メチルスルフイド3.5mlおよび無水HF35mlを加
え、60分間攪拌した。反応後、HFを減圧下留去し、
残渣にエーテルを加え、生じた沈澱物を集めた後、0.
1N酢酸に溶解した、この溶液をダウエックス×1(ア
セテート型)のカラム(3.5×12cm)に通し、ニン
ヒドリン陽性のフラクションのみを集め凍結乾燥して粗
生成物1.87gを得た。これを0.1N酢酸50mlに
溶かし、CM−セルロースのカラム(2×33cm) にチ
ャージし、0.05M酢酸アンモニウム(pH5.1)
1l〜0.4M酢酸アンモニウム(pH6.0)1lの
直線型濃度勾配による溶出を行った。各フラクションは
9.0mlづつ分画し、TLCによりRf6 =0.30付
近にスポットを有する74〜84本目のフラクションを
集め乾燥した。これを出来るだけ少量の0.1N塩酸に
溶かし、この溶液をセファデックスG−25のカラム
(3×115cm)にチャージし、0.1N酢酸で溶出し
た。各フラクションはUV280nmにおける吸光度を
測定し、1つの大きなピークを有するフラクションのみ
を集めて凍結乾燥して〔Nle8 ,Nle18,Ty
34〕−h−PTH(1−34)NH2 を得た。 収量;140mg、TLC;Rf6 =0.30 アミノ酸分析(3%チオグリコール酸含有6N塩酸で加
水分解);Asp3.98(4)、Ser2.10
(3)、Glu4.93(5)、Gly0.97
(1)、Val2.66(3)、Ile0.87
(1)、Leu5.00(5)、Tyr1.11
(1)、Lys3.26(3)、His2.30
(3)、Arg2.03(2)、Trp0.62
(1)、Nle2.22(2) 高速液体クロマトグラフイー; カラム;ヌクレオシル(Nucleosil)5
18(4mmI.D.×150mm)緩衝液;0.1Mリン酸
含有0.1%酢酸−アセトニトリル(アセトニトリルの
比率は最初の5分間は20%、その後の20分間は20
%〜40%の直線型濃度勾配による) 流速;1ml/分 検出;225nm 測定結果;19.07分にのみピーク検出。
43) [Nle 8 , Nle 18 , Try 34 ]
-H-PTH (1-34) NH 2 compound [42] 2.9 g (0.5 mM) under cooling to 0 ° C. anisole 3.5 ml, ethanedithiol 0.35 ml, dimethyl sulfide 3.5 ml and anhydrous HF 35 ml. Was added and stirred for 60 minutes. After the reaction, HF was distilled off under reduced pressure,
Ether was added to the residue, the resulting precipitate was collected, and
This solution dissolved in 1N acetic acid was passed through a Dowex × 1 (acetate type) column (3.5 × 12 cm), and only ninhydrin-positive fractions were collected and freeze-dried to obtain 1.87 g of a crude product. This was dissolved in 50 ml of 0.1N acetic acid and charged in a CM-cellulose column (2 × 33 cm), and 0.05M ammonium acetate (pH 5.1) was added.
Elution was performed with a linear concentration gradient of 1 liter of 1 liter to 0.4 M ammonium acetate (pH 6.0). Each fraction was fractionated into 9.0 ml, and the 74th to 84th fractions having spots near Rf 6 = 0.30 were collected by TLC and dried. This was dissolved in as little 0.1N hydrochloric acid as possible, this solution was charged into a Sephadex G-25 column (3 × 115 cm), and eluted with 0.1N acetic acid. The absorbance of each fraction was measured at UV280 nm, and only the fractions having one large peak were collected and freeze-dried [Nle 8 , Nle 18 , Ty.
r 34] was obtained -h-PTH (1-34) NH 2 . Yield: 140 mg, TLC; Rf 6 = 0.30 amino acid analysis (hydrolyzed with 6N hydrochloric acid containing 3% thioglycolic acid); Asp3.98 (4), Ser2.10.
(3), Glu4.93 (5), Gly0.97
(1), Val2.66 (3), Ile 0.87
(1), Leu5.00 (5), Tyr1.11
(1), Lys3.26 (3), His2.30.
(3), Arg2.03 (2), Trp0.62
(1), Nle 2.22 (2) High Performance Liquid Chromatography; Column; Nucleosil 5 C
18 (4 mm ID × 150 mm) buffer solution; 0.1% acetic acid-acetonitrile containing 0.1 M phosphoric acid (ratio of acetonitrile is 20% for the first 5 minutes, 20 for the subsequent 20 minutes)
Flow rate: 1 ml / min Detection: 225 nm Measurement result: Peak detection only at 19.07 min.

【0080】実施例1 〔Nle8 ,Nle18,Tyr34〕−h−PTH(1−
34)NH2 125 I標識体の調製 2mCiの放射活性を有する125 I−NaIを含有する
0.5Mリン酸緩衝液(pH7.1)50μlに〔Nl
8 ,Nle18,Tyr34〕−h−PTH(1−34)
NH2 の2μg含有液10μlおよびクロラミンT
(3.5mg/ml)含有液20μlを加えて30秒間攪拌
した後、これに重亜硫酸ナトリウム(4.5mg/ml)含
有液50μlを加えて反応を停止した。これに5%ヒト
血清アルブミン含有0.1N酢酸溶液0.5mlを加えた
後、セファデックスG−10のカラム(1×50cm)に
チャージし、上記酢酸溶液で溶出して125 Iで標識した
〔Nle8 ,Nle18,Tyr34〕−h−PTH(1−
34)NH2 を得た。
Example 1 [Nle 8 , Nle 18 , Tyr 34 ] -h-PTH (1-
34) Preparation of 125 I-labeled substance of NH 2 In 50 μl of 0.5 M phosphate buffer (pH 7.1) containing 125 I-NaI having a radioactivity of 2 mCi, [Nl
e 8, Nle 18, Tyr 34] -h-PTH (1-34)
10 μl of a solution containing 2 μg of NH 2 and chloramine T
After adding 20 μl of a solution containing (3.5 mg / ml) and stirring for 30 seconds, 50 μl of a solution containing sodium bisulfite (4.5 mg / ml) was added to stop the reaction. After adding 0.5 ml of a 0.1 N acetic acid solution containing 5% human serum albumin to this, the column was charged on a Sephadex G-10 column (1 × 50 cm), eluted with the above acetic acid solution and labeled with 125 I. Nle 8 , Nle 18 , Tyr 34 ] -h-PTH (1-
34) NH 2 was obtained.

【0081】<非放射性NaIによるペプチドの標識>
125 Iで標識したペプチドの物性については、上記方法
と同様に非放射性NaIを用いてI化を行なったのち、
生成物の物性を明らかにし、それと125 Iで標識したペ
プチドを比較検討することに決定した。すなわち、〔N
le8 ,Nle18,Tyr34〕−h−PTH(1−3
4)NH2 5mgを水2.5mlに溶解し、0.1Mリン酸
緩衝液(pH7.1)250μl、NaI(2.2mg/
ml)含有液200μlおよびクロラミンT(125mg/
ml)含有液100μlを加えて30秒間攪拌した後、こ
れに重亜硫酸ナトリウム(100mg/ml)含有液65μ
lを加えて反応を停止した。これをセファデックスG−
10のカラム(1×50cm)にチャージし、0.1N酢
酸溶液で溶出し、280nmに吸収をもつ分画を集め凍
結乾燥して、〔Nle8 ,Nle18,Tyr34〕−h−
PTH(1−34)NH2 のI化体を得た。
<Peptide labeling with non-radioactive NaI>
Regarding the physical properties of the peptide labeled with 125 I, the non-radioactive NaI was used for the I conversion as in the above method,
It was decided to clarify the physical properties of the product and to compare the peptide with 125 I-labeled peptide. That is, [N
le 8 , Nle 18 , Tyr 34 ] -h-PTH (1-3
4) Dissolving 5 mg of NH 2 in 2.5 ml of water, 250 μl of 0.1M phosphate buffer (pH 7.1), NaI (2.2 mg /
ml) containing solution 200 μl and chloramine T (125 mg /
ml) containing solution (100 μl) and stirred for 30 seconds, and then sodium bisulfite (100 mg / ml) containing solution (65 μl)
The reaction was stopped by adding l. This is Sephadex G-
10 columns (1 × 50 cm) were charged and eluted with 0.1N acetic acid solution, and fractions having absorption at 280 nm were collected and lyophilized to give [Nle 8 , Nle 18 , Tyr 34 ] -h-
An I-form of PTH (1-34) NH 2 was obtained.

【0082】得られた生成物を下に示した条件でHPL
C分析を行ったところ、溶出時間約25.8分(ピーク
−1)と約27.2分(ピーク−2)に二つのピークを
示した。(原料の〔Nle8 ,Nle18,Tyr34〕−
h−PTH(1−34)NH2 は約24.2分に溶出さ
れる。) 分析条件 機器;島津LC−6A 高圧グラジエントシステム カラム;YMC−PACK R−ODS−5(4.6mm
I.D.×250mm) 溶出液;0.1%TFA/CH3 CN 75/25→6
0/40(v/v,30分) 流速;1ml/分 検出;210nm、280nm
The product obtained was subjected to HPL under the conditions shown below.
When C analysis was performed, two peaks were shown at an elution time of about 25.8 minutes (peak-1) and about 27.2 minutes (peak-2). ([Nle 8 , Nle 18 , Tyr 34 ] of raw material-
h-PTH (1-34) NH 2 elutes at about 24.2 minutes. ) Analytical conditions Instrument; Shimadzu LC-6A high pressure gradient system column; YMC-PACK R-ODS-5 (4.6 mm)
I. D. × 250 mm) Eluent: 0.1% TFA / CH 3 CN 75/25 → 6
0/40 (v / v, 30 minutes) Flow rate: 1 ml / min Detection: 210 nm, 280 nm

【0083】そこで、これらの二つのピークをHPLC
により分離精製し、そしてピーク−1、ピーク−2のそ
れぞれをトリプシンを用いて酵素分解を行った後、HP
LCにより分析した。そして分離したそれぞれのトリプ
シン分解ピークを6N−HCl、110℃、24時間の
加水分解後アミノ酸分析を行った。その結果、アミノ酸
分析においてTyrを含まないトリプシン分解ピークは
アミノ酸組成、HPLCによる溶出時間がピーク−1、
ピーク−2で同等であった。Tyrを含むトリプシン分
解ピークはHPLCでの溶出時間が異なっていたので、
さらにFAB−MASSによる分析を行った。FAB−
MASSによりピーク−1から得られたTyrを含むト
リプシン分解ピークのMH+ は1013でアミノ酸順序
28から34のH−Leu−Gln−Asp−Val−
His−Asn−Tyr−NH2 に1ケI化されたもの
である。さらにピーク−2から得られたもののMH+
1139で2ケI化されたものである。以上のことによ
りピーク−1は〔NIe8 ,Nle18,Tyr34〕−h
−PTH(1−34)NH2 のTyrがモノヨウ素化さ
れたもの、ピーク−2はジヨウ素化されたものである。
Therefore, these two peaks were analyzed by HPLC.
And purified by the method described above, and enzymatically decomposing each of peak-1 and peak-2 with trypsin, and then HP
Analyzed by LC. Then, each of the separated trypsin decomposition peaks was subjected to amino acid analysis after hydrolysis for 24 hours at 6N-HCl and 110 ° C. As a result, in the amino acid analysis, the Tyr-free trypsin decomposition peak showed the amino acid composition, the elution time by HPLC was peak-1,
Peak-2 was equivalent. Since the trypsin decomposition peaks containing Tyr had different elution times on HPLC,
Further analysis by FAB-MASS was performed. FAB-
The trypsin-decomposed peak containing Tyr obtained from peak-1 by MASS had an MH + of 1013 and H-Leu-Gln-Asp-Val- of amino acid sequence 28 to 34.
It is converted to His-Asn-Tyr-NH 2 once. Further, MH + obtained from peak-2 is 1139 converted into 2 isomers. Peak -1 by the above [NIe 8, Nle 18, Tyr 34] -h
-PTH (1-34) NH 2 Tyr is monoiodinated, and Peak-2 is diiodinated.

【0084】<〔NIe8 ,Nle18,Tyr34〕−h
−PTH(1−34)NH2 125 I標識体の分析>分
析はHPLCにより行った。 分析条件 機器;島津LC−6A 高圧グラジエントシステム カラム;YMC AM−302ODS(4.6mmI.
D.×150mm) ミニガードカラム;ヌクレオシル(Nucleosi
l)100−5 C18(4mmI.D.×10mm) 溶出液;0.1%TFA/CH3 CN 69.3/3
0.7(v/v) 流速;1ml/分 検出器;島津SPD−6A(210nm)、RI検出器
RLC−701(Aloka)
<[NIe 8 , Nle 18 , Tyr 34 ] -h
-Analysis of 125 I-labeled PTH (1-34) NH 2 > Analysis was performed by HPLC. Analytical conditions Instrument: Shimadzu LC-6A high pressure gradient system column: YMC AM-302 ODS (4.6 mm I.D.
D. × 150mm) Mini Guard Column; Nucleosi (Nucleosi)
l) 100-5 C18 (4mmI.D. × 10mm ) eluent; 0.1% TFA / CH 3 CN 69.3 / 3
0.7 (v / v) Flow rate; 1 ml / min Detector; Shimadzu SPD-6A (210 nm), RI detector RLC-701 (Aloka)

【0085】上記の分析条件により〔Nle8 ,Nle
18,Tyr34〕−h−PTH(1−34)NH2 のモノ
ヨウ素化体およびジヨウ素化体はそれぞれ約13.5
分、約23.3分に溶出される。そこで、調製された
〔Nle8 ,Nle18,Tyr34〕−h−PTH(1−
34)NH2 125 I標識体を同様の条件で分析すると
モノヨウ素化〔125 I〕体、ジヨウ素化〔125 2 〕体
が約4:1(比放射活性)で得られた。125 I−Na
I、クロラミンT、反応時間により、この比率は変化す
るが、HPLCにより精製することにより単一なモノヨ
ウ素(125 I)体、あるいはジヨウ素(125 2 )体が
得られた。
Under the above analysis conditions, [Nle 8 , Nle
The monoiodinated and diiodinated forms of 18 , Tyr 34 ] -h-PTH (1-34) NH 2 are about 13.5 each.
Minute, about 23.3 minutes. Therefore, the prepared [Nle 8 , Nle 18 , Tyr 34 ] -h-PTH (1-
34) When 125 I-labeled NH 2 was analyzed under the same conditions, monoiodinated [ 125 I] and diiodinated [ 125 I 2 ] were obtained at about 4: 1 (specific radioactivity). 125 I-Na
This ratio varies depending on I, chloramine T, and reaction time, but a single monoiodine ( 125 I) form or diiodine ( 125 I 2 ) form was obtained by purification by HPLC.

【配列表】[Sequence list]

【0086】配列番号:1 配列の長さ:34 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている。 配列 Ser Val Ser Glu Ile Gln Leu Nle His Asn Leu Gly Lys His Leu Asn Ser Nle 1 5 10 15 Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His Asn Tyr 20 25 30
SEQ ID NO: 1 Sequence length: 34 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amidated. Sequence Ser Val Ser Glu Ile Gln Leu Nle His Asn Leu Gly Lys His Leu Asn Ser Nle 1 5 10 15 Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His Asn Tyr 20 25 30

【0087】配列番号:2 配列の長さ:4 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている。N末端おびC末端のアミノ酸は保護基により
保護されている。 配列 Val His Asn Tyr(Bzl-Cl2)
SEQ ID NO: 2 Sequence length: 4 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amide Has been converted. The N-terminal and C-terminal amino acids are protected by a protecting group. Sequence Val His Asn Tyr (Bzl-Cl 2 ).

【0088】配列番号:3 配列の長さ:5 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている。N末端おびC末端のアミノ酸は保護基により
保護されている。 配列 Asp(OBzl) Val His Asn Tyr(Bzl-Cl2) 30
SEQ ID NO: 3 Sequence length: 5 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amide Has been converted. The N-terminal and C-terminal amino acids are protected by a protecting group. Sequence Asp (OBzl) Val His Asn Tyr (Bzl-Cl 2 ) 30

【0089】配列番号:4 配列の長さ:6 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている。N末端から2番目およびC末端のアミノ酸は
保護基により保護されている。
SEQ ID NO: 4 Sequence length: 6 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amide Has been converted. The amino acid at the second position from the N-terminal and the C-terminal is protected by a protecting group.

【0090】配列番号:5 配列の長さ:4 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:各アミノ酸は保護基により保護されている。 配列 Arg(Tos) Lys(Z-Cl) Lys(Z-Cl) Leu 25SEQ ID NO: 5 Sequence length: 4 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: Each amino acid is protected by a protecting group ing. Sequence Arg (Tos) Lys (Z-Cl) Lys (Z-Cl) Leu 25

【0091】配列番号:6 配列の長さ:5 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:各アミノ酸は保護基により保護されている。 SEQ ID NO: 6 Sequence length: 5 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: Each amino acid is protected by a protecting group ing.

【0092】配列番号:7 配列の長さ:6 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:N末端から2番目を除き各アミノ酸は保護基
により保護されている。
SEQ ID NO: 7 Sequence length: 6 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: each except the second from the N-terminal The amino acid is protected by a protecting group.

【0093】配列番号:8 配列の長さ:12 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基ハアミド化さ
れている。各アミノ酸は保護基により保護されている場
合がある。 配列 Trp Leu Arg(Tos) Lys(Z-Cl) Lys(Z-Cl) Leu Gln Asp(OBzl) Val His Asn 25 30 Tyr(Bzl-Cl2)
SEQ ID NO: 8 Sequence length: 12 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group amidation of C-terminal Tyr Has been done. Each amino acid may be protected by a protecting group. Sequence Trp Leu Arg (Tos) Lys (Z-Cl) Lys (Z-Cl) Leu Gln Asp (OBzl) Val His Asn 25 30 Tyr (Bzl-Cl 2 ).

【0094】配列番号:9 配列の長さ:4 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:各アミノ酸は保護基により保護されている場
合がある。
SEQ ID NO: 9 Sequence length: 4 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: Each amino acid is protected by a protecting group There is a case.

【0095】配列番号:10 配列の長さ:5 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:各アミノ酸は保護基により保護されている場
合がある。
SEQ ID NO: 10 Sequence length: 5 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: Each amino acid is protected by a protecting group There is a case.

【0096】配列番号:11 配列の長さ:17 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている場合がある。 配列 Nle Glu(OBzl) Arg(Tos) Val Glu(OBzl) Trp Leu Arg(Tos) Lys(Z-Cl) Lys 20 25 (Z-Cl) Leu Glu Asp(OBzl) Val His Asn Tyr(Bzl-CL2) 30
SEQ ID NO: 11 Sequence length: 17 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amide It may have been Sequence Nle Glu (OBzl) Arg (Tos) Val Glu (OBzl) Trp Leu Arg (Tos) Lys (Z-Cl) Lys 20 25 (Z-Cl) Leu Glu Asp (OBzl) Val His Asn Tyr (Bzl-CL 2 ) 30

【0097】配列番号:12 配列の長さ:4 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:アミノ酸は保護基により保護されて場合があ
る。
SEQ ID NO: 12 Sequence length: 4 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: Amino acids protected by protecting groups There are cases.

【0098】配列番号:13 配列の長さ:5 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:アミノ酸は保護基により保護されて場合があ
る。
SEQ ID NO: 13 Sequence length: 5 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence features: Other information: Amino acids protected by protecting groups There are cases.

【0099】配列番号:14 配列の長さ:22 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている。アミノ酸は保護基により保護されている場合
がある。 配列 Lys(Z-Cl) His Leu Asn Ser(Bzl) Nle Glu(OBzl) Arg(Tos) Val Glu(OBzl) Trp 15 20 Leu Arg(Tos) Lys(Z-Cl) Lys(Z-Cl) Leu Gln Asp(OBzl) Val His Asn Tyr(Bzl-C 25 30 -Cl2)
SEQ ID NO: 14 Sequence length: 22 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amide Has been converted. The amino acid may be protected by a protecting group. Sequence Lys (Z-Cl) His Leu Asn Ser (Bzl) Nle Glu (OBzl) Arg (Tos) Val Glu (OBzl) Trp 15 20 Leu Arg (Tos) Lys (Z-Cl) Lys (Z-Cl) Leu Gln Asp (OBzl) Val His Asn Tyr (Bzl-C 25 30 -Cl 2 ).

【0100】配列番号:15 配列の長さ:4 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:N末端およびC末端のアミノ酸は保護基によ
り保護されている。
SEQ ID NO: 15 Sequence length: 4 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence features: Other information: N-terminal and C-terminal amino acids It is protected by a protecting group.

【0101】配列番号:16 配列の長さ:5 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:N末端およびC末端のアミノ酸は保護基によ
り保護されている場合がある。
SEQ ID NO: 16 Sequence length: 5 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence features: Other information: N-terminal and C-terminal amino acids It may be protected by a protecting group.

【0102】配列番号:17 配列の長さ:27 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:C末端フラグメント 配列の特徴: 他の情報:C末端Tyrのカルボキシル基はアミド化さ
れている。アミノ酸は保護基により保護されている場合
がある。 配列 Nle His Asn Leu Gly Lys(Z-Cl) His Leu Asn Ser(Bzl) Nle Glu(OBzl) Arg(To 10 15 20 s) Val Glu(OBzl) Trp Leu Arg(Tos) Lys(Z-Cl) Lys(Z-Cl) Leu Gln Asp(OB 25 30 zl) Val His Asn Tyr(Bzl-Cl2)
SEQ ID NO: 17 Sequence length: 27 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: C-terminal fragment Sequence characteristics: Other information: Carboxyl group of C-terminal Tyr is amide Has been converted. The amino acid may be protected by a protecting group. Sequence Nle His Asn Leu Gly Lys (Z-Cl) His Leu Asn Ser (Bzl) Nle Glu (OBzl) Arg (To 10 15 20 s) Val Glu (OBzl) Trp Leu Arg (Tos) Lys (Z-Cl) Lys (Z-Cl) Leu Gln Asp (OB 25 30 zl) Val His Asn Tyr (Bzl-Cl 2 )

【0103】配列番号:18 配列の長さ:4 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:N末端およびC末端のアミノ酸は保護基によ
り保護されている。
SEQ ID NO: 18 Sequence length: 4 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence characteristics: Other information: N-terminal and C-terminal amino acids It is protected by a protecting group.

【0104】配列番号:19 配列の長さ:5 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:アミノ酸は保護基により保護されている場合
がある。
SEQ ID NO: 19 Sequence length: 5 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence features: Other information: Amino acids protected by protecting groups There is a case.

【0105】配列番号:20 配列の長さ:6 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:中間部フラグメント 配列の特徴: 他の情報:アミノ酸は保護基により保護されている場合
がある。
SEQ ID NO: 20 Sequence length: 6 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Intermediate fragment Sequence features: Other information: Amino acids protected by protecting groups There is a case.

【0106】配列番号:21 配列の長さ:7 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:N末端フラグメント 配列の特徴: 他の情報:アミノ酸は保護基により保護されている場合
がある。
SEQ ID NO: 21 Sequence length: 7 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: N-terminal fragment Sequence characteristics: Other information: Amino acid protected by protecting group There is a case.

【0107】配列番号:22 配列の長さ:34 配列の型:アミノ酸 トポロジー:直鎖状 配列の種類:ペプチド フラグメント型:最終フラグメント 配列の特徴: 他の情報:アミノ酸は保護基により保護されている場合
がある。 配列 Ser(Bzl) Val Ser(Bzl) Glu(OBzl) Ile Gln Leu Nle His Asn Leu Gly Lys(Z-C 1 5 10 1) His Leu Asn Ser(Bzl) Nle Glu(OBzl) Arg(Tos) Val Glu(OBzl) Trp Leu Arg 15 20 25 (Tos) Lys(Z-Cl) Lys(Z-Cl) Leu Gln Asp(OBzl) Val His Asn Tyr(Bzl-Cl2) 30
SEQ ID NO: 22 Sequence length: 34 Sequence type: Amino acid Topology: Linear Sequence type: Peptide Fragment type: Final fragment Sequence characteristics: Other information: Amino acids are protected by protecting groups There are cases. Sequence Ser (Bzl) Val Ser (Bzl) Glu (OBzl) Ile Gln Leu Nle His Asn Leu Gly Lys (ZC 1 5 10 1) His Leu Asn Ser (Bzl) Nle Glu (OBzl) Arg (Tos) Val Glu (OBzl ) Trp Leu Arg 15 20 25 (Tos) Lys (Z-Cl) Lys (Z-Cl) Leu Gln Asp (OBzl) Val His Asn Tyr (Bzl-Cl 2 ) 30

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 G01N 33/53 B 8310−2J 33/534 8310−2J C07K 99:00 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location G01N 33/53 B 8310-2J 33/534 8310-2J C07K 99:00

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 式 H−配列番号:1−NH2 で表されるペプチドの34番目のTyrが1〜2個の
125 Iで標識された放射活性体。
1. A peptide represented by the formula H-SEQ ID NO: 1-NH 2 has a Tyr at position 34 of 1-2.
Radioactive substance labeled with 125 I.
JP3013849A 1991-01-10 1991-01-10 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2 Pending JPH0592995A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3013849A JPH0592995A (en) 1991-01-10 1991-01-10 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3013849A JPH0592995A (en) 1991-01-10 1991-01-10 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP58144016A Division JPS6034996A (en) 1983-08-05 1983-08-05 (nle8,nle18,tyr34)-h-pth(1-34)nh2

Publications (1)

Publication Number Publication Date
JPH0592995A true JPH0592995A (en) 1993-04-16

Family

ID=11844729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3013849A Pending JPH0592995A (en) 1991-01-10 1991-01-10 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2

Country Status (1)

Country Link
JP (1) JPH0592995A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009091363A (en) * 2008-11-21 2009-04-30 Asahi Kasei Pharma Kk Stabilized aqueous injectable solution of pth

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009091363A (en) * 2008-11-21 2009-04-30 Asahi Kasei Pharma Kk Stabilized aqueous injectable solution of pth

Similar Documents

Publication Publication Date Title
US4656250A (en) [Nle8, Nle18, Tyr34 or Phe34 ]-h-PTH peptide derivatives
CA2052375C (en) Parathyroid hormone derivatives
EP0561412B1 (en) Parathyroid hormone derivatives
CA1065856A (en) Derivatives of salmon calcitonin
Isobe et al. The amino‐acid sequence of the α subunit in bovine brain S‐100a protein
Andreu et al. Solid‐phase synthesis of PYLa and isolation of its natural counterpart, PGLa [PYLa‐(4–24)] from skin secretion of Xenopus laevis
US4206199A (en) Novel glucagon fragment and its derivatives
Photaki A New Synthesis of Oxytocin Using S-Acyl Cysteines as Intermediates1, 2
JPH0684400B2 (en) Novel growth hormone-free peptide
US5508382A (en) Peptides and processes for producing cyclic peptides
YANG et al. Synthesis of α‐and β‐melanocyte stimulating hormones
JPS6296499A (en) Calcitonin analogue having carboxyl-ended d-amino acid substituent
JPS5896052A (en) Preparation of highly active h-pth (1-34) amide
JPH0592995A (en) 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2
Rohde et al. Amino acid sequence of the N-terminal non-collagenous segment of dermatosparactic sheep procollagen type I
JP4793644B2 (en) Synthesis method of caged peptide
Samy et al. The reaction of cyanogen bromide with an ovine ICSH subunit: the sequence of the NH2-terminal forty amino acids
EP0478775B1 (en) Peptide derivatives
Bodanszky et al. Studies on the conformation of secretin: The position of the helical stretch
JP2777193B2 (en) Method for producing peptide
US5010174A (en) Novel calcitonin derivative and salt thereof
JPH0352479B2 (en)
JPH05320193A (en) Parathyroidal hormone derivative
JP2632410B2 (en) Method for removing protecting group from protected peptide
JPS6267099A (en) (nleb, 21,)-r-pth(1-34) peptide derivative

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 19941012